[go: up one dir, main page]

WO2010029065A1 - Composés d'imidazole et de triazole, leur utilisation et produits contenant ces composés - Google Patents

Composés d'imidazole et de triazole, leur utilisation et produits contenant ces composés Download PDF

Info

Publication number
WO2010029065A1
WO2010029065A1 PCT/EP2009/061615 EP2009061615W WO2010029065A1 WO 2010029065 A1 WO2010029065 A1 WO 2010029065A1 EP 2009061615 W EP2009061615 W EP 2009061615W WO 2010029065 A1 WO2010029065 A1 WO 2010029065A1
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
combination
corresponds
case
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/061615
Other languages
German (de)
English (en)
Inventor
Jens Renner
Jochen Dietz
Thomas Grote
Bernd Müller
Jan Klaas Lohmann
Sarah Ulmschneider
Alice GLÄTTLI
Marianna Vrettou
Wassilios Grammenos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of WO2010029065A1 publication Critical patent/WO2010029065A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Definitions

  • the present invention relates to imidazole and triazole compounds of the formula I.
  • X is CH or N
  • Z saturated or partially unsaturated hydrocarbon chain having from three to eight carbon atoms which, when it is partially unsaturated, containing one to three double bonds or one or two triple bonds, where Z can contain one, two, three, four or five substituents R z, wherein R z means:
  • R Z is halogen, cyano, nitro, cyanato (OCN), C -C 8 -alkyl, C 8 -HaIo- genalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 haloalkenyl, C 2 - C 8 -alkenyl, C 3 -C 8 -
  • Heteroatoms from the group O, N and S contain, or NA 3 A 4 , wherein two radicals R z , which are attached to the same carbon atom, together with the carbon atom to which they are attached, also form a C 3 - C ⁇ -cycloalkyl ring can; wherein A 3 , A 4 are defined as below;
  • R 1 is C 3 -C 10 -cycloalkyl, C 3 -C 10 -halocycloalkyl, C 3 -C 10 -cycloalkenyl, C 3 -C 10 -halocycloalkenyl, the abovementioned carbocycles being unsubstituted or one, two, three, four or five substituents independently selected from halo, hydroxy, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl and Cs Cs-haloalkynyl or 6- to 10-membered aryl, wherein the aryl is unsubstituted or contains one, two, three, four or five independently selected substituents L, wherein L means:
  • L is halogen, cyano, nitro, hydroxyl, cyanoato (OCN), C 1 -C 8 -alkyl, C 1 -C 8 -haloalkyl, C 2 -C -alkenyl, C 2 -C 8 -haloalkenyl, C 2 -C -alkynyl, C 3 -C 8 -alkyl Haloalkynyl, C 4 -C 10 -alkadienyl, C 4 -C 10 -haloalkadienyl, C 1 -C 8 -alkoxy,
  • Ci-Cs-haloalkoxy Ci-Cs-alkylcarbonyloxy, Ci-Cs-alkylsulfonyloxy, C2-Cs-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C3-C8-haloalkynyloxy, Cs-Cs-cycloalkyl, Cs Cs-halocycloalkyl, C3-C8-cycloalkenyl, C3-Cs-halocycloalkenyl, C3-Cs-cycloalkoxy, Cs-C ⁇ -cycloalkenyloxy, hydroxyimino-Cis-Cs-alkyl, C-C ⁇ -alkylene, oxy-C2-C4- alkylene,
  • Oxy-Ci-C3-alkyleneoxy, Ci-Cs-alkoximino-Ci-Cs-alkyl, C2-Cs-Alkenyloximino-d-C ⁇ -alkyl, CjrC ⁇ -Alkinyloximino-Ci-C ⁇ -alkyl, S ( O) n A 1 , C (OO) A 2 , C (SS) A 2 , NA 3 A 4 , phenoxy, phenyl, heteroaryloxy, heterocyclyloxy, heteroaryl, heterocyclyl, where in the abovementioned groups the heteroaryl is an aromatic five-, is a six- or seven-membered heterocycle and the heterocyclyl is a saturated or partially unsaturated five-, six- or seven-membered heterocycle, each containing one, two, three or four heteroatoms from the group O, N and S, wherein two substituents L, the the same carbon atom, together with the carbon atom to which they are attached,
  • n 0, 1 or 2;
  • a 1 is hydrogen, hydroxy, C 1 -C 8 -alkyl, C 1 -C 8 -haloalkyl, amino, C 1 -C 8 -
  • Alkylamino di-C 1 -C 8 -alkylamino, phenyl, phenylamino or phenyl-C 1 -C 8 -alkylamino;
  • a 2 is one of the groups mentioned at A 1 or C 2 -C 8 -alkenyl, C 2 -C 8 -haloalkenyl, C 2 -C 8 -alkynyl, C 2 -C 8 -haloalkynyl, C 1 -C -alkoxy,
  • Ci-Cs-haloalkoxy C2-Cs-alkenyloxy, C2-Cs-haloalkenyloxy, C2-Cs-alkynyloxy, C3-Cs-haloalkynyloxy, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C3-Cs-cycloalkoxy or C3- Cs-halo-cycloalkoxy;
  • a 3, A 4 are independently hydrogen, Ci-C 8 -alkyl, Cs-halo- genalkyl, C2-Cs alkenyl, C2-C8 haloalkenyl, C2-C8 alkynyl, Cs-Cs haloalkynyl , C3-Cs-Cycloalkyl, Cs-Cs-halocycloalkyl, C3-C8- Cycloalkenyl or C 3 -C 8 -halocycloalkenyl, phenyl or 5- or 6 -membered heteroaryl having one, two, three or four heteroatoms from the group O, N and S in the heterocycle;
  • the aliphatic and / or alicyclic and / or aromatic groups of the radical definitions of L may themselves carry one, two, three or four identical or different groups R L :
  • R L is halogen, hydroxy, cyano, nitro, Ci-C 8 alkyl, Ci-Cs-haloalkyl, d-Cs-alkoxy, d-Cs-haloalkoxy, C 3 -C 8 cycloalkyl, C 3 -C 8 -Halogencyclo alkyl, C 3 -C 8 -cycloalkenyl, C 3 -C 8 -cycloalkoxy, C 3 -C 8 -halocycloalkoxy, C 1 -C 6 -alkylene, oxy-C 2 -C 4 -alkylene, oxy-C 1 -C 3 - alkyleneoxy, C 8 - alkylcarbonyl, Ci-Cs-alkylcarbonyloxy, Ci-C8-alkoxycarbonyl, amino, d- C ⁇ -alkylamino, di-Ci-C 8 alkylamino;
  • R 2 is hydrogen, Ci-Cio-alkyl, Ci-Cio-haloalkyl, C 2 -Cio-alkenyl, C 2 -C 0 - haloalkenyl, C 2 -C 0 alkynyl, C3-Cio-haloalkynyl, C4-Cio-alkadienyl , C4-Ci ⁇ -Halogenalkadienyl, C3-Ci ⁇ cycloalkyl, C3-Ci ⁇ halocycloalkyl, C 3 - Cio-cycloalkenyl, C3-Cio-halocycloalkenyl;
  • R 3 is hydrogen, Ci-Cio-alkyl, Ci-Cio-haloalkyl, C 2 -C 0 alkenyl, C 2 -C 0 - haloalkenyl, C 2 -C 0 alkynyl, C3-Cio-haloalkynyl, C 4 -C 0- alkadienyl, C 1 -C 10 -haloalkadienyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -halocycloalkyl, C 3 -C 10 -cycloalkenyl, C 3 -C 10 -halocycloalkenyl, carboxyl, formyl, Si (A 5 A 6 A 7 ), C (O) R ⁇ , C (O) OR ⁇ , C (S) OR ⁇ , C (O) SR ⁇ , C (S) SR ⁇ , C (NR A ) SR ⁇ ,
  • R ⁇ is C 1 -C 8 alkyl, C 3 -C 8 alkenyl, C 3 -C 8 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkenyl or phenyl;
  • R is A -Cs alkyl, C 3 -C 8 alkenyl, C 3 -C 8 alkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkenyl or phenyl;
  • a 5 , A 6 , A 7 independently of one another are C 1 -C 10 -alkyl, C 3 -C 8 -alkenyl, C 3 -C 8 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl or phenyl ;
  • R ⁇ , R A , A 5 , A 6 and A 7 are independently unsubstituted or substituted with one, two, three, four or five L as defined above;
  • R 4 is hydrogen, Ci-C ⁇ alkyl, Ci-Cio-haloalkyl, C 2 -C 0 alkenyl, C 2 -C 0 - haloalkenyl, C 2 -C 0 alkynyl, C 3 -C 0 haloalkynyl, C4 -Cio-alkadienyl, C 4 -C 10 haloalkadienyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -halocycloalkyl, C 3 -C 10 -cycloalkenyl, C 3 -C 10 -halocycloalkenyl;
  • R 2 , R 3 , R 4 are, unless otherwise indicated, independently unsubstituted or substituted with one, two, three, four or five L as defined above;
  • R 5 is hydrogen, C 1 -C 10 -alkyl, C 1 -C 10 -haloalkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -alkyl
  • R 6 is hydrogen, halogen, C 2 -C 10 -alkyl, C 1 -C 10 -haloalkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -alkynyl or C 3 -C 8 -cycloalkyl;
  • R 7 is C 1 -C 10 -alkyl or C 1 -C 10 -haloalkyl
  • alkyl, alkenyl, alkynyl and cycloalkyl groups in R 5 , R 6 and R 7 are unsubstituted or substituted with one, two, three, four, five or six independently selected substituents L as defined above;
  • the invention relates to the preparation of the compounds I, the intermediates for the preparation of the compounds I and their preparation and the use of the compounds according to the invention for controlling phytopathogenic fungi and agents containing them.
  • Triazole compounds are known from EP 0 097 881, EP 0 129 186, EP 0 129 152.
  • the fungicidal action of the compounds known from the prior art leaves something to be desired, in particular at low application rates in some cases. It is an object of the present invention to provide novel compounds which preferably have improved properties, such as a better fungicidal action and / or better toxicological properties. This object has surprisingly been achieved with the compounds of the formula I described herein.
  • the compounds I are able to form salts or adducts with inorganic or organic acids or with metal ions because of the basic character of the nitrogen atoms contained in them. This also applies to most of the precursors for compounds I described herein, of which the salts and adducts are also subject of the present invention.
  • inorganic acids are hydrohalic acids such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, carbonic acid, sulfuric acid, phosphoric acid and nitric acid.
  • suitable organic acids are formic acid and alkanoic acids such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, alkylsulfonic acids (sulfonic acids having straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), Arylsulfonic acids or disulfonic acids (aromatic radicals such as phenyl and naphthyl which carry one or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids with straight-chain or branched alkyl radicals having 1 to 20 carbon atoms), arylphosphonic acids or diphosphonic acids (aromatic radicals such as phenyl and naphthyl which carry one or two phosphoric acid radicals), it being possible for the alkyl or aryl radicals such
  • the metal ions are, in particular, the ions of the elements of the second main group, in particular calcium and magnesium, the third and fourth main groups, in particular aluminum, tin and lead, and the first to eighth transition groups, in particular chromium, manganese, iron, cobalt, nickel, copper, Zinc and others into consideration. Particularly preferred are the metal ions of the elements of the subgroups of the fourth period.
  • the metals can be present in the various valences that belong to them.
  • the compounds I according to the invention can be prepared in various ways in analogy to prior art processes known per se (see, for example, the cited prior art).
  • the compounds of the invention can be prepared by the syntheses shown in the following Schemes.
  • R 1 , X, Y, Z, R 2 , R 5 , R 6 and R 7 are as defined or preferably defined for formula I, are prepared by reduction of the keto group from compounds II
  • Boron hydrides in particular sodium borohydride, potassium borohydride, tetra-n-butylammonium borohydride and other metal hydrides can be used as reducing agents, for example. It may be advantageous to add an additive such as a Lewis acid, generally in substoichiometric or stoichiometric proportions. Titanium halides such as titanium tetrachloride, titanium alkoxides such as titanium tetraisopropoxide or zinc or tin halides such as zinc chloride or tin chloride have proven particularly suitable. See, for example, Chem Ber. 121 (6), 1988, 1059 et seq. Further suitable reducing agents are e.g.
  • Alkyl magnesium halides e.g. Isopropylmagnesium chloride or tert-butylmagnesium chloride. See, e.g. DE351 1922, DE3437919, DE3415486, DE3600812.
  • Another object of the present invention are compounds of formula II
  • R 1 , X, Y, Z, R 2 , R 5 , R 6 and R 7 are as defined or preferably defined for formula I.
  • R 2 is hydrogen (compounds 11-1).
  • R 1 -YZ-LG (IV) and a base is reacted, wherein LG is a leaving group such as halogen, in particular Cl, Br and I, or mesylate, tosylate, or for any other skilled in the art known leaving group.
  • LG is a leaving group such as halogen, in particular Cl, Br and I, or mesylate, tosylate, or for any other skilled in the art known leaving group.
  • R 1 , Y and Z have the meanings or preferred meanings, as defined for formula I.
  • Suitable bases are alkali metal or alkaline earth metal hydrides, alkali metal amides or alkoxides.
  • LG is a leaving group (Bspe. see above) or OH, which, if Z contains one or more multiple bonds , is not tied directly to a multiple bond.
  • LG is substituted by a nucleophile such as an alkoxide to introduce a group R 1 -Y.
  • a nucleophile such as an alkoxide
  • R 1 -OH such as in particular a possibly substituted phenol
  • Suitable bases are carbonates, alkali metal or alkaline earth metal hydrides, alkali metal amides and alcoholates.
  • the reaction is usually carried out in a temperature range between 20 0 C and 150 0 C.
  • LG can also be generated from an OH group by methods known to the person skilled in the art. Examples which may be mentioned here are the reactions with sulfonyl chlorides or anhydrides (methanesulfonyl, trifluoromethylsulfonyl or tosyl) in the presence of an amine base or with halogenating reagents, such as PBr3 or HBr.
  • Compounds VI can be prepared by reacting a compound III (see above) with a compound VII,
  • LG-Z-LG in which Z is as defined or preferably defined for each formula I and LG is each independently a leaving group (Bspe. See above) and one of the two groups LG can also be OH, the leaving groups, if Z contains one or more multiple bindings, not directly tied to a multiple binding.
  • Z in particular represents alkylene chain # - [CH 2] n - #, in which # indicates the sites of attachment and n denotes 3 to 8, in particular 3 to 5.
  • Suitable bases are alkali metal or alkaline earth metal hydrides, alkali metal amides and alcoholates.
  • the temperature range of these reactions is preferably between -20 0 C and 160 0 C, in particular, the reaction is carried out in solvents such as DMF, NMP, cyclic or acyclic ethers.
  • solvents such as DMF, NMP, cyclic or acyclic ethers.
  • X, Z, R 2 R 5 , R 6 and R 7 are as defined or preferably defined for formula I and A is independently a d-C ⁇ -alkyl group, Cs-C ⁇ -cycloalkoxy group or OH by reacting with a Compound IX
  • R 1 -LG IX in which R 1 is as defined or preferably defined for formula I and LG is a leaving group.
  • Suitable leaving groups LG are halogen, preferably chlorine, bromine or iodine, alkylcarbonylate, benzoate, alkylsulfonate, haloalkylsulfonate or arylsulfonate, particularly preferably chlorine and bromine.
  • the reaction is usually carried out in the presence of a base and a catalyst, in particular in the presence of a palladium catalyst, as described, for example, in: Synth. Commun. Vol. 1 1, p. 513 (1981); Acc. Chem. Res. Vol. 15, pp. 178-184 (1982); Chem. Rev. Vol. 95, pp.
  • Suitable catalysts are tetrakis (triphenylphosphine) palladium (0); Bis (triphenylphosphine) palladium (II) chloride; Bis (acetonitrile) palladium (II) chloride; [1, 1 '- bis (diphenylphosphino) ferrocene] palladium (II) chloride / methylene chloride (1: 1) complex; Bbis [bis (1,2-diphenylphosphino) ethane] palladium (0); Bis [bis (1, 2-diphenylphosphino) butane] palladium (II) chloride; Palladium (II) acetate; Palladium (II) chloride; Palladium (II) acetate / tri-o-tolylphosphine complex or mixtures of phosphines and Pd salts or phosphines and Pd complexes, e.g.
  • Suitable bases are e.g. inorganic bases such as alkali metal or alkaline earth metal oxides such as lithium oxide, sodium oxide, calcium oxide and magnesium oxide, alkali metal or alkaline earth metal carbonates such as lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate and calcium carbonate. Also suitable are alkali metal or alkaline earth metal oxides such as lithium oxide, sodium oxide, calcium oxide and magnesium oxide, alkali metal or alkaline earth metal carbonates such as lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate and calcium carbonate. Also suitable are alkali metal
  • Bicarbonates such as sodium bicarbonate and alkali metal or alkaline earth metal alkoxides such as sodium methoxide, sodium ethanolate, potassium ethanolate or potassium tert-butoxide.
  • amine bases are suitable, in particular tertiary amines such as trimethylamine, triethylamine, diisopropylethylamine and N-methylpiperidine, or aromatic such as pyridines, substituted pyridines such as collidine, lutidine and 4-dimethylaminopyridine.
  • bases such as sodium carbonate, potassium carbonate, cesium carbonate, triethylamine and sodium bicarbonate are particularly advantageous.
  • the base is usually used in a molar ratio of 1: 1 to 1:10, preferably in a molar ratio of 1: 1.5 to 1: 5 relative to R 1 -LG.
  • the boron compound is used in a molar ratio of between 1: 1 and 1: 5, preferably between 1: 1 and 1: 2.5, based on R 1 -LG.
  • R 1 here preferably represents substituted phenyl.
  • the reaction is usually carried out in an inert organic solvent.
  • suitable solvents are aliphatic hydrocarbons, e.g. Pentane, hexane, cyclohexane and petroleum ether, aromatic hydrocarbons such as toluene, o-, m- or p-xylene, ethers, e.g. Diisopropyl ether, methyl tert-butyl ether, dioxane, anisole, tetrahydrofuran and dimethoxyethane.
  • ketones such as acetone, ethyl methyl ketone, diethyl ketone and methyl tert-butyl ketone are suitable.
  • solvents such as dimethyl sulfoxide, dimethylformamide and dimethylacetamide.
  • ethers such as tetrahydrofuran, dioxane and dimethoxyethane.
  • the o.g. Solvents may preferably also be used as mixtures with one another or in admixture with water.
  • the coupling reaction is usually carried out at temperatures between 20 and 180 0 C, preferably between 40 and 120 0 C.
  • X, Z, R 2 R 5 , R 6 and R 7 are as defined or preferably defined for formula I and A is independently a Ci-C ⁇ -alkyl group, Cs-C ⁇ -cycloalkoxy or OH, wherein Z is in particular a Alkyl chain # - [CH 2] n - #, where # indicates the attachment sites and n is in particular 1 to 3.
  • the borane compound used is, for example, 9-BBN, dicyclohexylborane, catecholborane, borane, dimethoxyborane borane, pinacolborane, texylborane.
  • These reactions are known to the person skilled in the art and can be carried out, for example, analogously to literature procedures, for example as described in WO 2008055859 or Journal of the American Chemical Society (2007), 129 (47), 14632-14639.
  • (transition) metal complexes as catalysts such as Ir (COD ⁇ Cb, Rh (Cl) (PPh3) 3 as described in Angewandte Chemie, 97 (10), 854-5, 1985, is possible.
  • Compounds X wherein Z is especially an alkylene chain # - [CH 2] n - #, where # indicates the sites of attachment and n is 1 to 4, can be prepared by reacting a ketone III (see above) via a conventional alkylation method as set forth above , is alkylated.
  • the oxirane XI is obtainable by reacting the corresponding olefin XII
  • a peracid or an equivalent reagent such as dimethyldioxirane or other peroxides, see also EP 0 236 884.
  • olefins XII can be prepared from over the corresponding alcohol XV which is converted into the olefin in an elimination reaction familiar to the person skilled in the art (see also EP 0 236 884).
  • the preparation of the alcohols XV is described, for example, in DE 3400829.
  • an isomerization of the double bond can take place in order to make the desired configuration of the oxirane available. Processes for this are known to the person skilled in the art.
  • Halogen fluorine, chlorine, bromine and iodine; Alkyl and the alkyl moieties of compound groups such as alkylamino: saturated, straight-chain or branched hydrocarbon radicals having 1 to 4, 6, 8 or 12 carbon atoms, for example Ci-C 6 alkyl such as methyl, ethyl, propyl, 1-methylethyl, butyl , 1-methylpropyl, 2-methylpropyl, 1, 1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1, 1 -Dimethylpropyl, 1, 2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1, 1-dimethylbutyl, 1, 2-dimethylbutyl, 1, 3-dimethylbutyl, 2,2-dimethylbutyl,
  • Haloalkyl alkyl as mentioned above, wherein in these groups partially or completely the hydrogen atoms are replaced by halogen atoms as mentioned above; in particular C 1 -C 2 -haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl , 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl or 1, 1 , 1-
  • Alkenyl and the alkenyl moieties in a compound group such as alkenyloxy: unsaturated, straight-chain or branched hydrocarbon radicals having 2 to 4, 2 to 6 or 2 to 8 carbon atoms and a double bond in any position.
  • alkenyloxy unsaturated, straight-chain or branched hydrocarbon radicals having 2 to 4, 2 to 6 or 2 to 8 carbon atoms and a double bond in any position.
  • alkenyl groups are, for example, C 2 -C 6 alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1 -propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl , 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3 -Methyl-3-butenyl, 1, 1-dimethyl-2-propenyl, 1, 2-dimethyl-1-propenyl, 1, 2-dimethyl-2-propenyl, 1-methyl
  • Alkadienyl unsaturated, straight-chain or branched hydrocarbon radicals having 4 to 6 or 4 to 8 carbon atoms and two double bonds in any position;
  • Alkynyl as well as the alkynyl moieties in compounded groups straight or branched chain hydrocarbon groups of 2 to 4, 2 to 6 or 2 to 8 carbon atoms and one or two triple bonds in any position, e.g. C 2 -C 6 -alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4- Pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1, 1-dimethyl-2-propynyl, 1-ethyl-2- propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-he
  • Haloalkynyl alkynyl as defined above, wherein in these groups the hydrogen atoms are partially or completely replaced by halogen atoms as described above under haloalkyl, in particular fluorine, chlorine or bromine;
  • Cycloalkyl and the cycloalkyl moieties in assembled groups mono- or bicyclic, saturated hydrocarbon groups having 3 to 8, in particular 3 to 6, carbon ring members, e.g. C3-C6 cycloalkyl such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
  • Halogencycloalkyl cycloalkyl as defined above, wherein in these groups the hydrogen atoms are partially or completely replaced by halogen atoms as described above under haloalkyl, in particular fluorine, chlorine or bromine;
  • Cycloalkenyl monocyclic, monounsaturated hydrocarbon groups with preferably 3 to 8 or 4 to 6, in particular 5 to 6 carbon ring members, such as cyclopenten-1-yl, cyclopenten-3-yl, cyclohexen-1-yl, cyclohexene-3 yl, cyclohexene-4-yl and the like;
  • Halocycloalkenyl cycloalkenyl as defined above, wherein in these groups the hydrogen atoms are partially or completely replaced by halogen atoms as described above under haloalkyl, in particular fluorine, chlorine or bromine; Alkoxy: for an oxygen-bonded alkyl group as defined above, preferably having 1 to 8, more preferably 2 to 6 carbon atoms.
  • Examples are: methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy or 1, 1-dimethylethoxy; and also, for example, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1, 1-dimethylpropoxy, 1, 2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy , 3-methylpentoxy, 4-methylpentoxy, 1, 1-dimethylbutoxy, 1, 2-dimethylbutoxy, 1, 3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2 Ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy;
  • Haloalkoxy alkoxy, as defined above, wherein in these groups the hydrogen atoms are partially or completely replaced by halogen atoms, as described above under haloalkyl, in particular fluorine, chlorine or bromine.
  • halogen atoms as described above under haloalkyl, in particular fluorine, chlorine or bromine.
  • examples of these are OCH 2 F, OCHF 2 , OCF 3 , OCH 2 Cl, OCHCl 2 , OCCl 3 , chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2 Difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,
  • Alkylene divalent linear chains of CH 2 groups. Preference is given to (C 1 -C 6) -alkylene, more preferably (C 2 -C 4) -alkylene, and furthermore it may be preferable to use (C 1 -C 3 ) -alkylene groups.
  • Examples of preferred alkylene radicals are CH 2 , CH 2 CH 2 , CH 2 CH 2 CH 2 , CH 2 (CH 2 ) 2 CH 2 , CH 2 (CH 2 ) 3 CH 2 and CH 2 (CH 2 ) 4 CH 2 ;
  • 6- to 10-membered aryl Aromatic hydrocarbon cycle containing 6, 7, 8, 9 or 10 carbon atoms in the ring. In particular phenyl or naphthyl.
  • tri- or four-membered saturated heterocycle (hereinafter also Heterocyc IyI) containing one or two heteroatoms from the group O, N and S as ring members;
  • hexahydroxene vinyls such as 2,3,4,5-tetrahydro [1 H] oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-Te - trahydro [1H] oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro [1H] oxepin 2-, -3-, -4-, -5-, -6- or -7-yl, hexahydroazepine-1, -2-, -3- or -4-yl, tetra- and hexahydro-1,3-diazepinyl, Tetra- and hexahydro-1,4-diazepinyl, tetra- and hexahydro-1,3-oxazepinyl, tetra- and hexahydro
  • the respective heterocycle may be attached via a carbon atom or via a nitrogen atom, if present. It may be preferred according to the invention that the respective heterocycle is bonded via carbon, on the other hand it may also be preferred for the heterocycle to be bonded via nitrogen.
  • the heterocycle means in particular:
  • 5-membered heteroaryl containing one, two, three or four nitrogen atoms or one, two or three nitrogen atoms and / or a sulfur or oxygen atom, which heteroaryl may be attached via C or N, if present: 5- ring heteroaryl groups which may contain, in addition to carbon atoms, one to four nitrogen atoms or one, two or three nitrogen atoms and / or one sulfur or oxygen atom as ring members, eg Furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl (1,2,3-; 1,2,4-triazolyl), tetrazolyl, oxazolyl, isoxazolyl, 1, 3,4-oxadiazolyl, thiazolyl, isothiazolyl and thiadiazolyl, especially 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-pyrrolyl, 3-isoxazolyl,
  • 6-membered heteroaryl containing one, two, three or four, preferably one, two or three nitrogen atoms, which heteroaryl can be attached via C or N, if present: 6-membered heteroaryl groups which, in addition to carbon atoms, have one to may contain four or one, two or three nitrogen atoms as ring members, eg Pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, 1, 2,3-triazinyl, 1, 2,4-triazinyl, 1, 3,5-triazinyl, especially 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4 Pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1, 3,5-triazin-2-yl and 1, 2,4-triazin-3-yl.
  • 6-membered heteroaryl groups which, in addition to carbon atoms
  • novel compounds of this invention contain chiral centers and are generally obtained in the form of racemates or as diastereomeric mixtures of erythro and threo forms.
  • the erythro and threo diastereomers can be included the compounds of the invention, for example, due to their different solubility or by column chromatography and isolate in pure form. From such uniform pairs of diastereomers can be obtained by known methods uniform enantiomers.
  • antimicrobial agents it is possible to use both the uniform diastereomers or enantiomers and also their mixtures obtained in the synthesis. The same applies to the fungicides.
  • the invention therefore relates both to the pure enantiomers or diastereomers and to mixtures thereof.
  • the scope of the present invention includes the (R) and (S) isomers and the racemates of the compounds of the invention, in particular of formula I, which have chiral centers.
  • Suitable compounds according to the invention, in particular of the formula I also include all possible stereoisomers (cis / trans isomers) and mixtures thereof.
  • the optionally occurring double bond (s) in the variable Z in the compounds according to the invention can be configured in each case (E) or (Z). Both the (E) and the (Z) isomers are the subject of the present invention.
  • the compounds according to the invention in particular of the formula I, can be present in various crystal modifications which may differ in their biological activity. They are also the subject of the present invention.
  • X N (triazole compounds of formula LA).
  • X CH (imidazole compounds of the formula LB).
  • Y is O. According to another embodiment of the invention, Y represents a single bond between R 1 and Z.
  • Z in the compounds of the invention is a saturated or partially unsaturated hydrocarbon chain having three, four, five, six, seven or eight carbon atoms which, when partially unsaturated, contains one, two or three double bonds or one or two triple bonds, where Z is one, two, three, four or five substituents R z may contain.
  • Z is a saturated hydrocarbon chain of three to eight carbon atoms wherein Z is unsubstituted or may contain one, two, three, four or five substituents R z .
  • Z stands for a group Z 1 : wherein # represent the attachment sites, n is 3, 4, 5, or 6, and R z1 and R z2 are each independently selected from hydrogen and R z , as defined herein.
  • n in the group Z 1 stands for 3.
  • n in the group Z 1 stands for 4.
  • n in the group Z 1 stands for 5.
  • R z1 and R z2 are each independently selected from hydrogen and R z , as defined herein, wherein R z is in particular selected from Ci-C 4 -AlkVl and Cs-C ⁇ -cycloalkyl, and / or R z1 and R z2 together with the carbon to which they are attached form a C3-C6 cycloalkyl ring.
  • R z is selected from F and Cl.
  • all R z1 and R z2 in Z 1 are hydrogen.
  • Z is a partially unsaturated hydrocarbon chain having two to eight, in particular four to six, carbon atoms which contains one to three double bonds, wherein Z may contain one, two, three, four or five substituents R z .
  • the hydrocarbon chain has a double bond. In another embodiment, the hydrocarbon chain has two double bonds.
  • Z is a group Z 2 in which # represent the attachment sites, m and p are each O, 1 or 2, where m + p> 1, in particular m + p> 2, and R Z1 , R Z2 , R Z3 , R Z4 , R Z5 and R Z6 are each independently selected from hydrogen and R z, wherein R z are each as defined herein or preferably defined.
  • R z3 and R z4 are independently selected from hydrogen and R z , as defined herein, wherein R z is in particular selected from Ci-C 4 -AlkVl, in particular methyl or ethyl.
  • R z1 , R z2 , R z5 and R z6 are each preferably independently selected from hydrogen and C 1 -C 4 -alkyl and / or two radicals on a carbon atom together with the carbon atom to which they are attached form a C 3 -C 6 -cycloalkyl ring.
  • R Z3 is hydrogen
  • R Z4 is selected from R z.
  • R Z4 is C 1 -C 4 -alkyl, in particular methyl.
  • R Z4 is halogen, in particular chlorine.
  • R Z4 is hydrogen
  • R Z3 is selected from R z.
  • R Z3 is C 1 -C 4 -alkyl, in particular methyl.
  • R Z3 is halogen, in particular chlorine.
  • R Z3, and R Z4 are independently selected from R z.
  • R Z4 and R Z3 mean Ci-C 4 alkyl, especially methyl.
  • R Z3 is halogen, in particular chlorine.
  • R Z1 , R Z2 , R Z5 and R Z6 are hydrogen.
  • R Z1 , R Z2 , R Z5 and R Z6 are independent of each other. which is selected from hydrogen and halogen (especially F and Cl), wherein at least one R z thereof is not hydrogen.
  • the double bond in the group Z 2 can be configured (E) or (Z). Both the (E) and the (Z) isomers are the subject of the present invention. In one embodiment, the double bond (E) is configured. According to another embodiment, the double bond (Z) is configured.
  • Z is a partially unsaturated hydrocarbon chain having three to eight, in particular four to six, carbon atoms which contains one or two triple bonds, wherein Z may contain one, two, three, four or five substituents R z .
  • the hydrocarbon chain has a triple bond. In another embodiment, the hydrocarbon chain has two triple bonds.
  • Z stands for a group Z 3
  • # represent the attachment sites
  • m and p are each 0, 1 or 2, where m + p> 1, preferably m + p> 2, and R Z1 , R Z2 , R Z3 and R Z4 are each independently selected is hydrogen and R z , where R z is each as defined herein or preferably defined.
  • R z1 , R z2 , R z3 and R z4 are independently selected from hydrogen and R z , as defined herein, wherein R z is in particular selected from Ci-C 4 -AlkVl, in particular methyl or E. - Thyl.
  • the substituent R z on Z or in the group Z 1 , Z 2 and Z 3 is / are, unless stated otherwise, each independently selected from the group halogen, cyano, nitro, cyanoato (OCN), Ci -C 8 -alkyl, C 8 haloalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 - haloalkenyl, C 2 -C 8 -alkyl kinyl, C3-C8-haloalkynyl, Ci-C 8 alkoxy, Ci-C 8 - haloalkoxy, Ci-C8-alkylcarbonyloxy, Ci-C 8 alkylsulfonyloxy, C 2 -C 8 alkenyloxy, C 2 - C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C3 -C 8 haloalkynyloxy, C3-C8 cycloalkyl, C
  • R z 2 is each independently halogen, cyano, nitro, cyanato (OCN), C -C -alkyl 8 -alkyl, Ci-C 8 haloalkyl, C 2 -C 8 alkenyl, C -C 8 haloalkenyl, C 2 -C 8 -alkyl kinyl, C 3 -C 8 haloalkynyl, C 8 alkoxy, Ci-C8-haloalkoxy, Ci-C 8 -
  • a fourth alkylsulfonyloxy C 2 -C 8 alkenyloxy, C 2 -C 8 haloalkenyloxy, C 2 -C 8 alkynyloxy, C3-C8 haloalkyny
  • R z is C 2 -C each independently Cl, F, Br, cyano, Ci-C 4 alkyl, Ci-C 4 haloalkyl, 4 -alkenyl, C 2 -C 4 haloalkenyl, Ci- C 4 -Alk- oxy, Ci-C 4 haloalkoxy, Cs-C ⁇ -cycloalkyl or Cs-C ⁇ -halocycloalkyl, in particular methyl, ethyl, trifluoromethyl, methoxy, ethoxy or cyclopropyl.
  • At least one R z denotes halogen, in particular Cl or F.
  • At least one R z is C 1 -C 4 -alkyl, in particular methyl or ethyl.
  • At least one R z is CrC 4 - haloalkyl.
  • two R z radicals attached to the same carbon atom together with the carbon atom to which they are attached form a Cs-C ⁇ cycloalkyl ring.
  • R 1 in the compounds according to the invention is C 3 -C 8 -cycloalkyl, Cs-C 8 -HiIo- gencycloalkyl, C 3 -C 10 -cycloalkenyl, C 3 -C 10 -halocycloalkenyl, where the abovementioned groups are unsubstituted or one, two, three, four or five substituents independently selected from halogen, hydroxy, Ci-C 8 alkyl, Ci-C 8 haloalkyl, C 2 -C 8 - alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, and C3-C 8 haloalkynyl; or 6- to 10-membered aryl wherein the aryl is unsubstituted or contains one, two, three, four or five independently selected substituents L.
  • R 1 is substituted 6- to 10-membered aryl, in particular substituted
  • R 1 is phenyl which contains exactly one substituent L 1 .
  • L 1 is selected from F, Cl, Br, cyano, Ci-C 4 -alkyl, Ci-C4-haloalkyl, -C 4 -alkoxy, Ci-C4-haloalkoxy, C3-C6-cycloalkyl and Cs C ⁇ -halocycloalkyl, in particular F, Cl, Br, methyl, trifluoromethyl, difluoromethyl and methoxy.
  • L 1 is selected from F, Cl and Br.
  • R 1 is phenyl which contains a substituent L 1 and a substituent L 2 , and may additionally contain one, two or three independently selected substituents L, where L, L 1 and L 2 are as L (see below) are defined.
  • L 1 and L 2 are each independently selected from the group consisting of Cl, F, Br, cyano, nitro, hydroxy, C1-C4 alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci -C 4 haloalkoxy, and the optionally contained further one, two or three substituents L are independently selected from L, as defined herein or preferably defined.
  • R 1 is phenyl which may contain a substituent L 1 which is Cl and may additionally contain one, two, three or four independently selected substituents L, each L being independently as defined herein.
  • the phenyl group is substituted in the 2-position with Cl.
  • the phenyl group of this embodiment is substituted in the 3-position with Cl.
  • the phenyl group of this embodiment is substituted in the 4-position with Cl.
  • the phenyl group is substituted by Cl and contains exactly one further substituent L 2 .
  • the phenyl group is 2,3-disubstituted.
  • the phenyl group is 2,4-disubstituted.
  • the phenyl group is 2,5-disubstituted.
  • the phenyl group is 2,6-disubstituted.
  • the phenyl group is substituted by Cl and contains exactly two further substituents, L 2 and L 3 .
  • R 1 is phenyl which may contain a substituent L 1 which is F and may additionally contain one, two, three or four independently selected substituents L, each L being independently as defined herein.
  • the phenyl group is substituted in the 2-position with F.
  • the phenyl group of this in the 3-position substituted with F.
  • the phenyl group of this embodiment is substituted in the 4-position with F.
  • the phenyl group is substituted by F and contains exactly one further substituent L 2 .
  • the phenyl group is 2,3-disubstituted.
  • the phenyl group is 2,4-disubstituted.
  • the phenyl group is 2,5-disubstituted.
  • the phenyl group is 2,6-disubstituted.
  • F stands in each case in the 2-position.
  • the second substituent L 2 is preferably selected from F, Cl, Br, methyl and methoxy.
  • the phenyl group is 2,3-, 2,4-, 2,5- or 2,6-difluoro-substituted. According to another specific embodiment, the phenyl group is 2-fluoro-3-chloro, 2-fluoro-4-chloro, 2-fluoro-5-chloro or 2-fluoro-6-chloro substituted.
  • the phenyl group is substituted by F and contains exactly two further substituents, L 2 and L 3 .
  • R 1 is phenyl which may contain a substituent L 1 which is methyl and may additionally contain one, two, three or four independently selected substituents L, each L being independently as defined herein.
  • the phenyl group is substituted in the 2-position with methyl.
  • the phenyl group of this embodiment is substituted in the 3-position with methyl.
  • the phenyl group of this embodiment is substituted in the 4-position with methyl.
  • the phenyl group is 2,3-disubstituted.
  • the phenyl group is 2,4-disubstituted.
  • the phenyl group is 2,5-disubstituted.
  • the phenyl group is 2,6-disubstituted.
  • R 1 is phenyl which may have a substituent L 1 which is methoxy and may additionally contain one, two, three or four independently selected substituents L, each L being independently as defined herein.
  • the phenyl group is substituted in the 2-position with methoxy.
  • the phenyl group of this embodiment is substituted in the 3-position with methoxy.
  • the phenyl group of this embodiment is substituted in the 4-position with methoxy.
  • the phenyl group is 2,3-disubstituted.
  • the phenyl group is 2,4-disubstituted.
  • the phenyl group is 2,5-disubstituted.
  • the phenyl group is 2,6-disubstituted.
  • R 1 is phenyl containing three, four or five substituents L, where L is independently defined as defined herein or preferred.
  • R 1 is a 2,3,5-trisubstituted phenyl ring. In another embodiment, R 1 is a 2,3,4-trisubstituted phenyl ring. In yet another embodiment, R 1 is a 2,4,5-trisubstituted phenyl ring. In yet another embodiment, R 1 is a 2,4,6-trisubstituted phenyl ring. In yet another embodiment, R 1 is a 2,3,6-trisubstituted phenyl ring. According to one embodiment, at least one of the three substituents is Cl. According to one embodiment, at least one of the three substituents is F. According to a further embodiment, at least one of the three substituents is methyl. In yet another embodiment, at least one of the three substituents is methoxy.
  • R 1 is disubstituted by two L's
  • L is in each case independently selected from Cl, F, Br, cyano, nitro, hydroxy, C 1 -C 4 -alkyl and C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy and C 1 -C 4 -haloalkoxy.
  • L is in each case independently selected from Cl, F, C 1 -C 4 -alkyl and C 1 -C 4 -haloalkyl.
  • each L is independently selected from Cl, F, Br, cyano, methyl, ethyl, iso -propyl, tert -butyl, trifluoromethyl, methoxy, ethoxy and trifluoromethoxy.
  • R 1 is C 3 -C 10 -cycloalkyl or C 3 -C 10 -halocycloalkyl.
  • R 1 is C 3 -C 7 -cycloalkyl, in particular cyclopropyl (C-C3H5), cyclopentyl (C-C5H9), cyclohexyl (C-C6Hn) or cycloheptyl (C-C7H13), which may be substituted in each case could be.
  • Specific examples of R 1 are 1-chlorocyclopropyl, 1-methylcyclopropyl, 1-chlorocyclopentyl, 1-methylcyclopentyl and 1-methylcyclohexyl.
  • R 1 is C 3 -C 10 cycloalkenyl or C 3 -C 10 halocycloalkenyl.
  • R 2 is hydrogen, C 1 -C 10 -alkyl, C 1 -C 10 -halogenoalkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -haloalkenyl, C 2 -C 10 -alkynyl, C 3 -C 10 -haloalkynyl, C 4 -C 4 -ioi Alkadienyl, C 4 -C 10 -haloalkadienyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -halo genocycloalkyl, C 3 -C 10 -cycloalkenyl or C 3 -C 10 -halocycloalkenyl, where R 2 has one, two, three, four or five substituents L, as defined herein.
  • R 2 is hydrogen
  • R 2 is C 1 -C 10 -alkyl, C 1 -C 10 -haloalkyl, phenyl-C 1 -C 4 -alkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -haloalkenyl, C 2 -C 10 -alkynyl, C -C 3 0 - haloalkynyl, C4-Cio-alkadienyl, C4-Cio-Halogenalkadienyl, C3-Cio-cycloalkyl, C 3 -C 0 - halocycloalkyl, C3-Cio-cycloalkenyl or C3-Cio-halocycloalkenyl, in particular Ci-C4- Alkyl, C 2 -C 4 alkenyl, C 3 -C 4 alkynyl or phenyl-C 1 -C 4 alkyl.
  • R 2 are methyl, ethyl, n-propyl, iso-propyl, n-butyl, tert-butyl, 2-vinyl, 3-allyl, 3-propargyl, 4-but-2-ynyl and benzyl.
  • R 3 is hydrogen, Ci-Cio-alkyl, Ci-Cio-haloalkyl, C 2 -Cio-alkenyl, C 2 -Cio-haloalkenyl, C 2 -Cio-alkynyl, C 3 -Cio -haloalkynyl, C 4 -Cio Alkadienyl, C 4 -C 10 haloalkadienyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -halo genocycloalkyl, C 3 -C 10 -cycloalkenyl, C 3 -C 10 -halocycloalkenyl, carboxyl, formyl, Si (A 5 A 6 A 7 ) , C (O) R ⁇ , C (O) OR ⁇ , C (S) OR ⁇ , C (O) SR ⁇ , C (S) SR ⁇ , C (C (S)
  • a 1 is hydrogen, hydroxy, C 1 -C 8 -alkyl, C 1 -C 5 -haloalkyl, amino, C 1 -C 8 -alkylamino,
  • R Ci-C 8 alkyl, C 3 -C 8 alkenyl, C 3 -C 8 -alkyl kinyl, C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkenyl or phenyl;
  • R A is C 1 -C 8 -alkyl, C 3 -C 8 -alkenyl, C 3 -C 8 -alkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -cycloalkenyl or phenyl;
  • R ⁇ , R A , A 5 , A 6 and A 7 are independently unsubstituted or substituted with one, two, three, four or five L, as defined above.
  • R 3 may contain one, two, three, four or five substituents L as defined herein.
  • R 3 is hydrogen
  • R 3 is C 1 -C 10 -alkyl, C 1 -C 10 -haloalkyl, phenyl-C 1 -C 10 -alkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -haloalkenyl, C 2 -C 10 -alkynyl, C 3 -C 0 - haloalkynyl, C4-Cio-alkadienyl, C4-Cio-Halogenalkadienyl, C3-Cio-cycloalkyl, C 3 -C 0 - halocycloalkyl, C3-Cio-cycloalkenyl, C3-Cio-halocycloalkenyl, carboxyl, formyl, Si ( A 5 A 6 A 7 ), C (O) R ⁇ , C (O) OR ⁇ , C (S) OR ⁇ , C (O)
  • a 1 is hydroxy, C 1 -C 4 -alkyl, phenyl or C 1 -C 4 -alkylphenyl;
  • R Ci-C 4 alkyl, carboxy-Ci-C 4 alkyl or carboxyphenyl;
  • R A is C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl or phenyl;
  • a 5 , A 6 , A 7 are independently C 1 -C 4 alkyl or phenyl wherein the phenyl ring is unsubstituted or substituted with one, two, three, four or five L as defined herein.
  • R 3 is trimethylsilyl
  • R 4 is hydrogen, Ci-Cio-alkyl, Ci-Ci 0 -HaIo- genalkyl, C 2 -C 0 alkenyl, C 2 -C 0 haloalkenyl, C 2 -C 0 alkynyl, C 3 - Ci 0 haloalkynyl, C 4 -C 0 -alkadienyl, C 4 -Cio-Halogenalkadienyl, C 3 -C 0 cycloalkyl, C 3 -C 0 -HaIo- gencycloalkyl, C 3 -C 0 cycloalkenyl or C 3 -C 0 halocycloalkenyl, wherein R 4 may contain one, two, three, four or five substituents L, as defined herein.
  • R 4 is hydrogen
  • R 4 is Ci-Cio-alkyl, Ci-Cio-haloalkyl, phenyl-Ci-C 4 alkyl, C 2 -C 0 alkenyl, C 2 -C 0 haloalkenyl, C 2 -C 0 - alkynyl, C 3 -C 0 - haloalkynyl, C 4 -Cio-alkadienyl, C 4 -Cio-Halogenalkadienyl, C 3 -C 0 cycloalkyl, C 3 -C 0 - halocycloalkyl, C 3 -C 0 cycloalkenyl or C 3 -Ci 0 -halocycloalkenyl, in particular Re d-Ce-alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or phenyl-Ci-C 4 alkyl.
  • R 5 is hydrogen, C 1 -C 10 -alkyl, C 1 -C 10 -haloalkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -alkynyl or C 3 -C 8 -cycloalkyl, preferably hydrogen or C 1 -C 4 -alkyl.
  • R 5 is in particular hydrogen, methyl, ethyl or n-propyl.
  • R 5 is hydrogen.
  • R 5 is methyl.
  • R 6 is hydrogen, halogen, C 2 -C 10 -alkyl, C 1 -C 10 -haloalkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -alkynyl or C 1 -C 8 -cycloalkyl, preferably hydrogen, halogen, C 2 -C 4 alkyl, C2-C 4 alkenyl or Cs-C ⁇ cycloalkyl.
  • R 6 is in particular hydrogen, ethyl or n-propyl.
  • R 6 is hydrogen.
  • R 6 is halogen, in particular Cl or F.
  • R 6 is C 3 -C 6 -cycloalkyl, such as cyclopropyl.
  • R 7 is C 1 -C 10 -alkyl or C 1 -C 10 -haloalkyl, preferably C 1 -C 4 -alkyl.
  • R 7 is in particular methyl, ethyl, n-propyl or n-butyl. In a specific embodiment, R 7 is methyl. In another specific embodiment, R 7 is ethyl. In yet another specific embodiment, R 7 is n-propyl.
  • the said alkyl groups in R 5 , R 6 and R 7 and also the radicals mentioned as being preferred are unsubstituted or substituted by one, two, three, four, five or six independently selected substituents L as defined herein. In one embodiment, none of the radicals is substituted by L.
  • L is selected from Ci-C4 alkyl, Ci-C 4 haloalkyl, C 2 -C 4 - alkenyl, and halogen (particularly Cl and / or F), Cs-C ⁇ cycloalkyl. Specific examples are cyclopropyl, methylcyclopropyl, trifluoromethyl and difluoromethyl.
  • CR 5 R 6 R 7 means:
  • CH 2 CH 2 CH 3, CH (CHs) 2, CH 2 (CH 2 J 2 CH 3, C (CHs) 2 CH 2 CH 3, C (CH 3) 2 CH (CH 3) 2, C (CH 3 ) 2 C (CH3) 3 CH 2 (CH (CHs) 2, CH 2 C (CHs) 3, CH (CH 3) C (CH 3) 3, CH (CH 3) CH (CHs) 2, C (CH 3 ) (CH 2 F) 2 , C (CH 2 ) 2 F, CH (CH 3 ) CH [CH 2 CH 2 ], or C (CH 2 ) 2 CH CH 2
  • L is preferably independently selected from halogen, cyano, nitro, cyanato (OCN), CrC 4 - Alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C 3 -C 6 cycloalkyl, C 3 -
  • a 1 is hydrogen, hydroxy, Ci -C4 -alkyl, Ci-C 4 haloalkyl;
  • a 2 is one of the groups mentioned at A 1 or C 1 -C 4 -alkoxy, C 1 -C 4 -
  • Haloalkoxy C 3 -C 6 -cycloalkyl, Cs-C ⁇ -halocycloalkyl, C 3 -C ⁇ -cycloalkoxy or C 3 -C 6 -halocycloalkoxy;
  • a 3 , A 4 independently of one another are hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl;
  • R L is halogen, cyano, nitro, Ci-C alkyl 4 -alkyl, Ci-C 4 haloalkyl, Ci-C 4 - alkoxy, Ci-C4-haloalkoxy, C3-C6-cycloalkyl, Cs-C ⁇ -halocycloalkyl, Amino, Ci-Cs-alkylamino, di-Ci-Cs-alkylamino.
  • L is independently selected from halogen, amino Ci-C 4 -alkyl, C d- 4 alkoxy, Ci-C4-haloalkyl, Ci-C4-haloalkoxy, Ci-C 4 alkylamino, -C 4 - dialkylamino , Thio and C 1 -C 4 -alkylthio
  • L is independently selected from halogen, Ci-C 4 -alkyl, C 4 - haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy.
  • L is independently selected from F, Cl, Br, CH 3, C 2 H 5, iC 3 H 7, tC 4 H 9, OCH 3, OC 2 H 5, CF 3, CCl 3, CHF 2 , CCIF 2 , OCF 3 , OCHF 2 and SCF 3 , in particular selected from F, Cl, CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , CF 3 , CHF 2 , OCF 3 , OCHF 2 and SCF 3 , According to one embodiment, L is independently selected from F, Cl, CH 3, OCH 3, CF 3, OCF 3 and OCHF. 2 It may be preferred that L is independently F or Cl.
  • L is independently selected from F, Br, CH 3, C 2 H 5, iC 3 H 7, tC 4 H 9, OCH 3, OC 2 H 5, CF 3, CCl 3, CHF 2 CCIF 2 , OCF 3 , OCHF 2 and SCF 3 .
  • L is independently selected F, Cl, Br, methyl and methoxy.
  • CR 5 R 6 R 7 is CH (CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA5aA-1 to IA5aA-444)
  • Table 13a Compounds LA, wherein Z is CH 2 CH 2 CH (CH 3 ) CH 2 CH 2 , R 2 , R 3 and R 4 are H, CR 5 R 6 R 7 is CH (CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA13aA-1 to IA13aA-444)
  • Line of Table A corresponds (compounds I.A.30aA-1 to I.A.30aA-444)
  • CR 5 R 6 R 7 is CH 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA34aA-1 to IA34aA-444)
  • Row of Table A corresponds (compounds I.A.35aA-1 to I.A.35aA-444)
  • Table 39a Compounds LA, wherein Z is C (CH 2 CH 2 ) (CH 2 ) 3 CH 2 , R 2 , R 3 and R 4 are H, CR 5 R 6 R 7 is CH 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA39aA-1 to IA39aA-444) Table 40a
  • Row of Table A corresponds (compounds I.A.43aA-1 to I.A.43aA-444)
  • CR 5 R 6 R 7 is CH 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA47aA-1 to IA47aA-444)
  • Table 56a compounds LA wherein Z is CH 2 (CH 2 ) 2 CH 2 , R 2 , R 3 and R 4 are H,
  • Row of Table A corresponds (compounds I.A.57aA-1 to I.A.57aA-444)
  • Line of Table A corresponds (compounds I.A.65aA-1 to I.A.65aA-444)
  • CR 5 R 6 R 7 is C (CH 3 ) 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA83aA-1 to IA83aA-444)
  • CR 5 R 6 R 7 is C (CH 2 ) 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA88aA-1 to IA88aA-444)
  • CR 5 R 6 R 7 is C (CH 2 ) 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA98aA-1 to IA98aA-444)
  • CR 5 R 6 R 7 is C (CH 3 ) 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA105aA-1 to IA105aA-444)
  • CR 5 R 6 R 7 is C (CH 3 ) 2 CH 2 CH 3 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA108aA-1 to IA108aA-444) Table 109a
  • Table 1 11 a Compounds LA, wherein Z is CH 2 (CH 2 ) 3 CH 2 , R 2 , R 3 and R 4 are H,
  • CR 5 R 6 R 7 is C (CH 3 ) (CH 2 CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA111 aA-1 to IA11 1aA-444)
  • CR 5 R 6 R 7 is C (CH 3 ) (CH 2 CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA116aA-1 to I.A116aA-444)
  • CR 5 R 6 R 7 is C (CH 3 ) (CH 2 CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA128aA-1 to IA128aA-444) Table 129a
  • CR 5 R 6 R 7 is C (CH 3 ) 2 CH (CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA137aA-1 to IA137aA-444)
  • Table 138a
  • Table 140a compounds LA wherein Z is CH 2 CH 2 CH (CH 3 ), R 2 , R 3 and R 4 are H,
  • CR 5 R 6 R 7 is C (CH 3 ) 2 CH (CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA140aA-1 to IA140aA-444)
  • Table 145a Compounds LA, wherein Z is CH 2 CH (CH 3 ) (CH 2 ) 2 CH 2 , R 2 , R 3 and R 4 are H, CR 5 R 6 R 7 C (CH 3 ) 2 CH ( CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA145aA-1 to IA145aA-444)
  • Table 146a compounds LA wherein Z is C (CH 3 ) 2 (CH 2 ) 3 CH 2 , R 2 , R 3 and R 4 are H,
  • CR 5 R 6 R 7 is C (CH 2 ) 2 CH (CH 2 ) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA146aA-1 to IA146aA-444)
  • CR 5 R 6 R 7 is C (CH 2 ) 2 CH (CH 2 ) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA152aA-1 to IA152aA-444)
  • CR 5 R 6 R 7 is C (CH 2 ) 2 C (CH 3 ) 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA166aA-1 to IA166aA-444)
  • Table 167a Table 167a
  • CR 5 R 6 R 7 is C (CH 2 ) 2 C (CH 3 ) 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA169aA-1 to IA169aA-444)
  • Table 175a Compounds LA, wherein Z is CH 2 CH 2 CH (CHS) CH 2 CH 2 , R 2 , R 3 and R 4 are H, CR 5 R 6 R 7 C (CHs) 2 C (CHs) 3 and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA175aA-1 to IA175aA-444)
  • Table 176a Compounds LA, wherein Z is CH 2 CH 2 CH 2 CH (CHS) CH 2 , R 2 , R 3 and R 4 are H, CR 5 R 6 R 7 C (CH 2 ) 2 C (CH 3 ) 3 and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA176aA-1 to IA176aA-444) Table 177a
  • CR 5 R 6 R 7 is C (CH 3 ) 2 C (CHs) 3, and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA179aA-1 to IA179aA-444)
  • CR 5 R 6 R 7 is CH (CH 3 ) C (CH 3 ) 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA193aA-1 to IA193aA-444)
  • CR 5 R 6 R 7 is CH (CH 3 ) C (CH 3 ) 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA205aA-1 to IA205aA-444)
  • Table 206a
  • CR 5 R 6 R 7 is CH (CH 3 ) C (CH 3 ) 3 and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA209aA-1 to IA209aA-444)
  • Table 210a
  • CR 5 R 6 R 7 is CH (CH 3 ) CH (CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA218aA-1 to IA218aA-444)
  • CR 5 R 6 R 7 is CH (CH 3 ) CH (CHs) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA223aA-1 to IA223aA-444)
  • CR 5 R 6 R 7 is CH (CH 3 ) CH (CHs) 2 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA243aA-1 to IA243aA-444) Table 244a
  • CR 5 R 6 R 7 is CH 2 CH (CH 3 ) 2 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA246aA-1 to IA246aA-444)
  • Row of Table A corresponds (compounds I.A.247aA-1 to I.A.247aA-444)
  • Table 251 a Compounds LA, wherein Z is CH 2 C (CH 2 CH 2 ) CH 2 , R 2 , R 3 and R 4 are H,
  • Row of Table A corresponds (compounds I.A.252aA-1 to I.A.252aA-444)
  • Row of Table A corresponds (compounds I.A.263aA-1 to I.A.263aA-444)
  • Line of Table A corresponds (compounds I.A.271aA-1 to I.A.271aA-444)
  • Row of Table A corresponds (compounds I.A.274aA-1 to I.A.274aA-444)
  • CR 5 R 6 R 7 is CH 2 C (CH 3 ) 3 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA278aA-1 to IA278aA-444)
  • Line of Table A corresponds (compounds I.A.279aA-1 to I.A.279aA-444)
  • Table 283a Compounds LA, wherein Z is CH 2 CH 2 CH (CH 3 ) CH 2 CH 2 , R 2 , R 3 and R 4 are H, CR 5 R 6 R 7 CH 2 C (CH 3 ) 3 , and the combination of R 1 and Y corresponds in each case to one row of Table A (compounds IA283aA-1 to IA283aA-444) Table 284a
  • CR 5 R 6 R 7 is CH 2 C (CH 3 ) 3 , and the combination of R 1 and Y corresponds in each case to one line of Table A (compounds IA286aA-1 to IA286aA-444)
  • Line of Table A corresponds (compounds I.A.287aA-1 to I.A.287aA-444)
  • Table 304a compounds LA wherein Z is CH 2 C (CH 2 ) 2 CH 2 , R 2 , R 3 and R 4 are H,
  • Table 307a Compounds LA, wherein Z is CH 2 CH (CH 3 ) (CH 2 ) 2 CH 2 , R 2 , R 3 and R 4 are H, CR 5 R 6 R 7 CH (CH 3 ) CH [CH 2 CH 2 ], and the combination of R 1 and
  • connection names for the individual connections are derived as follows: eg. is the "compound LA.3aA- ⁇ 0" (markers added) the compound of the formula LA according to the invention in which Z is CHb (CHb) SCHb, R 2 , R 3 and R 4 are hydrogen and CR 5 R 6 R 7 CH (CHs) 2 is (as indicated in Table 3a) and R 1 is 4-cyanophenyl and Y is O (as indicated in line ⁇ O of Table A).
  • the compounds of the formula I or the compositions according to the invention are suitable as fungicides for controlling harmful fungi. They are distinguished by outstanding activity against a broad spectrum of phytopathogenic fungi, including soil-borne pathogens, which in particular originate from the classes of the Plasmodiophoromycetes, Peronosporomycetes (Syn. Oomycetes), Chytriomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (Syn. Fungi imperfecti). They are partially systemically effective and can be used in crop protection as foliar, pickling and soil fungicides. In addition, they are suitable for combating fungi that attack, among other things, the wood or the roots of plants.
  • the compounds I and the compositions according to the invention for combating a multiplicity of pathogenic fungi on various crop plants, such as cereals, eg. Wheat, rye, barley, triticale, oats or rice; Beets, z. Sugar or fodder beets; Kernel, stone and berry fruits, z. Apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, currants or gooseberries; Legumes, z. Beans, lentils, peas, alfalfa or soybeans; Oil plants, e.g.
  • Rapeseed mustard, olives, sunflowers, coconut, cocoa, castor beans, oil palm, peanuts or soya
  • Cucurbits z. Pumpkins, cucumbers or melons
  • Fiber plants z. Cotton, flax, hemp or jute
  • Citrus fruits z. Oranges, lemons, grapefruit or mandarins
  • Vegetables z. Spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, squash or paprika
  • Energy and raw material plants eg.
  • Corn soy, wheat, rapeseed, sugarcane or oil palm; Corn; Tobacco; Nuts; Coffee; Tea; bananas; Wine (table and grapes); Hop; Grass, z. B. lawn; Rubber plants; Ornamental and forest plants, z. As flowers, shrubs, deciduous and coniferous trees and on the propagation material, for. B. seeds, and the crop of these plants.
  • the compounds I or the inventive composition Compositions for combating a variety of fungal pathogens in crops eg. Potatoes, sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugarcane; Fruit, vine and ornamental plants and vegetables, eg. As cucumbers, tomatoes, beans and pumpkins and on the propagation material, for. As seeds, and the crop of these plants used.
  • plant propagating materials includes all generative parts of the plant, e.g. As seeds, and vegetative plant parts, such as cuttings and tubers (eg., Potatoes), which can be used to propagate a plant. These include seeds, roots, fruits, tubers, bulbs, rhizomes, shoots and other plant parts, including seedlings and seedlings, which are transplanted after germination or emergence.
  • the young plants can be treated by a partial or complete treatment, eg. B. by immersion or pouring, are protected from harmful fungi.
  • the treatment of plant propagating materials with compounds I or the compositions according to the invention is used for combating a variety of fungal pathogens in cereal crops, e.g. Wheat, rye, barley or oats; Rice, corn, cotton and soy used.
  • crops also includes those plants which have been modified by breeding, mutagenesis or genetic engineering, including biotechnological agricultural products currently on the market or under development (see for example http://www.bio.org/speeches/pubs/er/agrLproducts .asp).
  • Genetically engineered plants are plants whose genetic material has been altered in a manner that does not occur under natural conditions by crossing, mutations or natural recombination (i.e., rearrangement of genetic information). As a rule, one or more genes are integrated into the genome of the plant in order to improve the properties of the plant.
  • Such genetic engineering also includes post-translational modifications of proteins, oligo- or polypeptides, e.g. by glycolylation or binding of polymers such as e.g. prenylated, acetylated or farnelysierter residues or PEG residues.
  • hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors such as hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, acetolactate synthase (ALS) -I inhibitors such.
  • HPPD hydroxyphenylpyruvate dioxygenase
  • ALS acetolactate synthase
  • Sulfonylureas EP-A 257 993, US Pat. No. 5,013,659
  • imidazolinones for example US Pat. No. 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO 98/02526, WO 98/02527, WO 04 / 106529, WO 05/20673, WO 03/14357, WO 03/13225,
  • EPSPS Enolpyruvylshikimat-3-phosphate synthase
  • Glyphosate see, for example, WO 92/00377
  • glutamine synthetase (GS) inhibitors such as. Glufosinate (see eg EP-A 242 236, EP-A 242 246) or oxynil Herbicides (see, for example, US 5,559,024).
  • crop plants such as soybean, produces cotton, corn, beets and rape, which are resistant to glyphosate or glufosinate, and sold under the trade name rou- dupReady ® (glyphosate-resistant, Monsanto, USA) and Liberty Link ® (Glufosinat- resistant, Bayer CropScience, Germany) are available.
  • rou- dupReady ® glyphosate-resistant, Monsanto, USA
  • Liberty Link ® Glufosinat- resistant, Bayer CropScience, Germany
  • plants are included which, with the aid of genetic engineering measures one or more toxins, eg. B. those from the bacterial strain Bacillus produce.
  • Toxins produced by such genetically engineered plants include e.g. Insecticidal proteins of Bacillus spp., In particular B. thuringiensis such as the endotoxins CrylAb, CrylAc, CrylF, Cry1Fe2, Cry2Ab, Cry3A, Cry3Bb1, Cry9c, Cry34Ab1 or Cry35Ab1; or vegetative insecticidal proteins (VIPs), e.g. VIP1, VIP2, VIP3, or VIP3A; insecticidal proteins of nematode-colonizing bacteria, e.g. B.
  • VIP1, VIP2, VIP3, or VIP3A insecticidal proteins of nematode-colonizing bacteria
  • Photorhabdus spp. or Xenorhabdus spp . Toxins from animal organisms, eg. B. Wepsen, spider or scorpion toxins; fungal toxins, e.g. Eg from Streptomyces; herbal lectins, e.g. From pea or barley; agglutinins; Proteinase inhibitors, e.g. Trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; Ribosome Inactivating Proteins (RIPs), e.g. Ricin, corn RIP, abrin, luffin, saporin or bryodin; Steroid metabolizing enzymes, e.g.
  • RIPs Ribosome Inactivating Proteins
  • 3-hydroxy steroid oxidase ecdysteroid IDP glycosyltransferase, cholesterol oxidase, ecdysone inhibitors, or HMG-CoA reductase
  • ion channel blocker e.g. B. inhibitors of sodium or calcium channels
  • Juvenile hormone esterase e.g. B. inhibitors of sodium or calcium channels
  • Receptors for the diuretic hormone (helicokinin receptors) e.g. B. inhibitors of sodium or calcium channels
  • Receptors for the diuretic hormone (helicokinin receptors) helicokinin receptors
  • Stilbene synthase bibenzyl synthase, chitinases and glucanases.
  • These toxins can also be produced in the plants as proteoxins, hybrid proteins, truncated or otherwise modified proteins.
  • Hybrid proteins are characterized by a novel combination of different protein domains (see, for example, WO 2002/015701). Further examples of such toxins or genetically modified plants which produce these toxins are described in EP-A 374 753, WO 93/07278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03 / 18810 and WO 03/52073. The methods for producing these genetically modified plants are known in the art and z. As set forth in the publications mentioned above.
  • toxins confer on the plants that produce them tolerance to pests of all taxonomic arthropod classes, in particular to beetles (Coeleropta), diptera and butterflies (Lepidoptera) and nematodes (Nematoda). Genetically engineered plants that produce one or more genes encoding insecticidal toxins, e.g. As described in the publications mentioned above and partly commercially available, such as. B.
  • YieldGard ® (corn cultivars producing the toxin CrylAb), YieldGard ® Plus (corn cultivars producing the toxins CrylAb and Cry3Bb1), StarLink ® (corn cultivars producing the toxin Cry9c), Herculex ® RW (corn cultivars toxins which Cry34Ab1, Cry35Ab1 and the enzyme phosphinothricin-N-acetyl producing transferase [PAT]); NuCOTN ® 33B (cotton cultivars producing the toxin CrylAc), Bollgard ® I (cotton cultivars producing the toxin CrylAc), Bollgard ® Il (cotton cultivars producing the toxins CrylAc and Cry2Ab2); VIP COT ® (cotton cultivars producing a VIP-toxin); NewLeaf ® (potato cultivars producing the Cry3A toxin); Bt Xtra ®, NatureGard® ®, KnockOut ®
  • plants which produce by genetic engineering measures one or more proteins that cause increased resistance or resistance to bacterial, viral or fungal pathogens, such as.
  • B. so-called pathogenesis-related proteins PR proteins, see EP-A O 392 225
  • resistance proteins eg, potato varieties that produce two resistance genes against Phytophthora infestans from the Mexican wild potato Solanum bulbocastanum
  • T4 lysozyme For example, potato varieties that are resistant to bacteria such as Erwinia amylvora through the production of this protein.
  • plants are included whose productivity has been improved by genetic engineering methods by z.
  • yield eg biomass, grain yield, starch, oil or protein content
  • tolerance to drought e.g., drought, salt or other limiting environmental factors or resistance to pests and fungal, bacterial and viral pathogens may be increased.
  • plants are also included whose ingredients have been modified, in particular to improve human or animal nutrition, with the aid of genetic engineering methods.
  • As oil plants producing health long-chain omega-3 fatty acids or monounsaturated omega-9 fatty acids eg Nexera ® - rape, DOW Agro Sciences, Canada.) Produce.
  • plants are included, which have been modified for the improved production of raw materials by means of genetic engineering methods by z.
  • the compounds I or the compositions according to the invention are suitable for controlling the following plant diseases:
  • Albugo spp. White rust on ornamental plants, vegetable crops (eg A. Candida) and sunflowers (eg BA tragopogonis); Alternaria spp. (Blackness, black spotiness) on vegetables, oilseed rape (for example B. brassicola or A. brassicae), sugar beet (for example BA tenuis), Fruit, rice, soya beans and potatoes (eg BA solani or A. alternata) and tomatoes (eg BA solani or A. alternata) and Alternaria spp. (Earwires) on wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, eg.
  • Botrytis cinerea Botryotina fuckeliana: gray mold, gray mold) on berry and pome fruit (including strawberries), vegetables (including lettuce, carrots, celery and cabbage), oilseed rape, flowers, vines, forestry crops and wheat (ear fungus); Bremia lactucae (downy mildew) on salad; Ceratocystis (Syn. Ophiostoma) spp. (Bläuepilz) on deciduous and coniferous trees, z.
  • Botrytis cinerea Triomorph: Botryotina fuckeliana: gray mold, gray mold) on berry and pome fruit (including strawberries), vegetables (including lettuce, carrots, celery and cabbage), oilseed rape, flowers, vines, forestry crops and wheat (ear fungus); Bremia lactucae (downy mildew) on salad; Ceratocystis (Syn. Ophiostoma) spp. (Bläuepilz)
  • BC ulmi elm dying, Dutch elm disease
  • Cercospora spp. Cercospora leaf spot
  • maize eg BC zeae-maydis
  • sugar beets eg BC beticola
  • sugarcane vegetables
  • coffee soybeans
  • soybeans eg BC sojina or C. kikuchii
  • Cladosporium spp. on tomato eg BC fulvum: velvet spot disease
  • cereals eg.
  • BC herbarum (earwax) on wheat; Claviceps purpurea (ergot) on cereals; Cochliobolus (Anamorph: Helminthosporium or Bipolaris) spp. (Leaf spotting) on maize (eg BC carbonum), cereals (eg BC sativus, anamorph: B. sorokiniana: brown spot) and rice (eg BC miyabeanus, anamorph: H. oryzae); Colletotricum (teleomorph: Glomerella) spp.
  • BC gossypii cotton
  • maize eg BC graminicola: stalk rot and stinging spots
  • soft fruit potatoes
  • potatoes eg BC coccodes: wilting
  • beans eg BC lindemuthianum
  • soybeans BC truncatum
  • Corticium spp. Z. BC sasakii (leaf sheath burn) on rice
  • Corynespora cassiicola leaf spot
  • soybeans and ornamental plants Cycloconium spp., Z. BC oleaginum on olive
  • ampelina burning spots); Entyloma oryzae (leaf sting) on rice; Epicoccum spp. (Earwig black) on wheat; Erysiphe spp. (Powdery mildew) on sugar beet (E. betae), vegetables (eg BE pisi), such as cucumber (for example BE cichoracearum) and cabbage plants, such as rapeseed (for example, B. cruciferarum); Eutypa lata (Eutypa crab or extinction, anamorphic Cytosporina lata, Syn. Libertella blepharis) on fruit trees, vines and ornamental plants. woody plants; Exserohilum (Syn.
  • Helminthosporium) spp. on maize eg BE turcicum
  • Fusarium (Teleomorph: Gibberella) spp. Wild, root and stalk rot
  • BF graminearum or F. culmorum root rot and Tauboder whiteness
  • F. culmorum root rot and Tauboder whiteness
  • F. oxysporum on tomatoes
  • F. solani on soybeans
  • F. verticillioides on maize
  • Gaeumannomyces graminis blackleg
  • cereals eg BG zeae
  • rice eg BG fujikuroi: Bakanae disease
  • BH vastatrix (coffee leaf rust) of coffee; Isariopsis clavispora (Syn. Cladosporium vitis) on grapevine; Macrophomina phasolina (Syn. Phaseoli) (root / stem rot) on soybeans and cotton; Micro- nium (Syn. Fusarium) nivale (snow mold) on cereals (eg wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., Z. BM laxa, M. fructicola and M. fructigena (flower and lace drought) on stone fruits and other rosaceae; Mycosphaerella spp.
  • BM graminicola Anamorph: Septoria tritici, Septoria leaf drought
  • M. fijiensis Black sigatoka disease
  • Peronospora spp. Downy mildew
  • cabbage for example BP brassicae
  • oilseed rape for example P. parasitica
  • onion plants for example B. destructor
  • tobacco for example P. tabacina
  • soybeans for example P. manshurica
  • Grapevines eg BP tracheiphila and P. tetraspora
  • soybeans eg BP gregata: stalk disease
  • Phoma Hungary root and stem rot
  • oilseed rape and cabbage and P. betae leaf spots
  • Phomopsis spp. on sunflowers
  • grapevine eg BP viticola: black spot disease
  • soybeans eg stalk rot: P. phaseoli, teleomorph: Diaporthe phaseolorum
  • Physoderma maydis (brown spot) on maize
  • BP capsici e.g. BP capsici
  • soybeans eg BP megasperma, Syn. P. sojae
  • potatoes and tomatoes eg. BP infestans: herbaceous and brown rot
  • deciduous trees eg BP ramorum: sudden oak mortality
  • Plasmodiophora brassicae cabbage hernia
  • Plasmopara spp. E.g. BP viticola (vine peronospora, fawn powdery mildew) on vines and P.
  • Podosphaera spp. Panosphaera spp. (Powdery mildew) of rosaceae, hops, kernels and berries, eg. BP leucotricha to apple; Polymyxa spp., Z. To cereals such as barley and wheat (P. graminis) and sugar beet (P. betae) and the viral diseases conferred thereby; Pseudocercosporella herpotrichoides (straw break, teleomorph: Tapesia yallundae) on cereals, e.g. Wheat or barley; Pseudoperonospora (downy mildew) on various plants, e.g.
  • BP cubensis on cucurbits or P. humili on hops Pseudo-pezicula tracheiphila (red burner, anamorph: Phialophora) on grapevine; Puccinia spp. (Rust disease) on various plants, eg. BP triticina (wheat brown rust), P. striiformis (yellow rust), P. hordei (dwarf rust), P. graminis (black rust) or P. recondita (rye brown rust) on cereals, such as.
  • BP asparagi Pyrenophora (anamorph: Drechslera) tritici-repentis (leaf drought) on wheat or P. teres (net stains) on barley; Pyricularia spp., E.g. BP oryzae (Teleomorph: Magnaporthe grisea, rice leaf-fire) on rice and P. grisea on lawn and crops; Pythium spp. (Turnip disease) on turf, rice, corn, wheat, cotton, oilseed rape, sunflower, sugar beets, vegetables and other plants (eg BP ultimum or P.
  • Pyrenophora anamorph: Drechslera
  • tritici-repentis leaf drought
  • P. teres net stains
  • Pyricularia spp. E.g. BP oryzae (Teleomorph: Magnaporthe grisea, rice leaf-fire) on rice and P. grisea on lawn and crops
  • BR solani root / stem rot
  • R. solani leaf-sheathing
  • cerealis pointed eye-spot on wheat or barley; Rhizopus stolonifer (soft rot) on strawberries, carrots, cabbage, grapevine and tomato; Rhynchosporium secalis (leaf spot) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotinia spp. (Stem or white rot) in vegetables and crops such as oilseed rape, sunflowers (eg Sclerotinia sclerotium rum) and soybeans (eg BS rolfsii); Septoria spp. on different plants, eg.
  • BS glycines leaf spot on soybeans, S. tritici (Septoria leaf drought) on wheat and S. (Syn. Stagonospora) nodorum (leaf and spelled tan) on cereals; Uncinula (Syn. Erysiphe) necator (powdery mildew, anamorphic: Oidium tuckeri) on grapevine; Sexspaeria spp. (Leaf spot) on corn (for example, S. turcicum, Syn. Helminthosporium turcicum) and turf; Sphacelotheca spp.
  • pruni (pocket disease) on plums; Thielaviopsis spp. (Black root rot) on tobacco, pome fruit, vegetable crops, soybeans and cotton, eg. BT basicola (Syn: Chalara elegans); Tilletia spp. (Stone or Stinkbrand) of cereals, such. BT tritici (Syn. T. caries, Weizensteinbrand) and T. controversa (Zwergsteinbrand) on wheat; Typhula incarnata (snow) on barley or wheat; Urocystis spp., E.g. BU occulta (stalk firing) on rye; Uromyces spp.
  • the compounds I and the compositions according to the invention are suitable in addition to the control of harmful fungi in the storage protection (also of crops) and in the protection of materials and buildings.
  • material and building protection covers the protection of technical and non-living materials such. As adhesives, glues, wood, paper and cardboard, textiles, leather, color dispersions, plastics, coolants, fibers and tissues, against the infestation and destruction by unwanted microorganisms such as fungi and bacteria.
  • Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp .; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp.
  • Tyromyces spp. Deuteromycetes such as Aspergillus spp., Cladosporium spp., Penicillium spp., Trichoderma spp., Alternaria spp., Paecilomyces spp. and Zygomycetes such as Mucor spp., moreover, in the protection of the following yeasts: Candida spp. and Saccharomyces cerevisae.
  • the compounds of the formula I can be present in various crystal modifications whose biological activity can be different. These are included in the scope of the present invention.
  • the compounds I and the compositions according to the invention are suitable for increasing plant health.
  • the invention relates to a method for increasing plant health by treating the plants, the plant propagating material and / or the place where the plants are to grow or grow with an effective amount of the compounds I or the compositions according to the invention.
  • plant health includes those conditions of a plant and / or its crop which are determined by different indicators individually or in combination with each other, such as yield (eg increased biomass and / or increased content of utilizable ingredients), Plant vitality (eg, increased plant growth and / or greener leaves), quality (eg, increased content or composition of certain ingredients), and tolerance to biotic and / or abiotic stress.
  • yield eg increased biomass and / or increased content of utilizable ingredients
  • Plant vitality eg, increased plant growth and / or greener leaves
  • quality eg, increased content or composition of certain ingredients
  • tolerance to biotic and / or abiotic stress e.g., tolerance to biotic and / or abiotic stress.
  • the compounds I are used as such or in the form of a composition by the harmful fungi, their habitat or the plants to be protected against fungal attack, plant propagating materials, eg. As seeds, the soil, surfaces, materials or spaces treated with a fungicidally effective amount of the compounds I.
  • plant propagating materials eg. As seeds, the soil, surfaces, materials or spaces treated with a fungicidally effective amount of the compounds I.
  • the application may be both before and after the infection of the plants, plant propagation materials, eg. As seeds, the soil, the surfaces, materials or spaces made by the fungi.
  • Plant propagating materials may be treated preventively together with or even before sowing or together with or even before transplanting with compounds I as such or with a composition containing at least one compound I.
  • the invention relates to agrochemical compositions containing a solvent or solid carrier and at least one compound I and their use for controlling harmful fungi.
  • An agrochemical composition contains a fungicidally effective amount of a compound I.
  • effective amount means an amount of the agrochemical composition or compound I which is sufficient to control harmful fungi on crop plants or in material and building protection and not to a considerable extent Such an amount may vary within a wide range and is influenced by numerous factors such as the fungus to be controlled, the particular crop or material being treated, the climatic conditions and compounds.
  • the compounds I, their N-oxides and their salts can be converted into the types customary for agrochemical compositions, e.g. As solutions, emulsions, suspensions, dusts, powders, pastes and granules.
  • the type of composition depends on the respective purpose; It should in any case ensure a fine and uniform distribution of the compound according to the invention.
  • composition types are suspensions (SC, OD, FS), emulsifiable concentrates (EC), emulsions (EW, EO, ES), pastes, pastilles, wettable powders or dusts (WP, SP, SS, WS, DP, DS) or granules (GR, FG, GG, MG), which can either be soluble (soluble) or dispersible (wettable) in water, as well as gels for the treatment of plant propagation materials such as seeds (GF).
  • composition types eg EC, SC, OD, FS, WG, SG, WP, SP, SS, WS, GF
  • composition types such as DP, DS, GR, FG, GG and MG are generally used undiluted.
  • agrochemical compositions are prepared in a known manner (see, for example, US 3,060,084, EP-A 707,445 (for liquid concentrates), Browning, "Agglomeration", Chemical Engineering, Dec. 4, 1967, 147-48, Perry's Chemical Engineer's Handbook, 4 th ed., McGraw-Hill, New York, 1963, 8-57 and et seq., WO 91/13546, US 4,172,714, US 4,144,050, US 3,920,442, US 5,180,587, US 5,232,701, US
  • the agrochemical compositions can furthermore also contain auxiliaries customary for crop protection agents, the choice of auxiliaries being based on the specific application form or the active substance.
  • auxiliaries are solvents, solid carriers, surface-active substances (such as further solubilizers, protective colloids, wetting agents and adhesives), organic and inorganic thickeners, bactericides, antifreeze agents, defoamers, if appropriate dyes and adhesives (for example for seed treatment). ,
  • Suitable solvents include water, organic solvents such as medium to high boiling point mineral oil fractions such as kerosene and diesel oil, coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, e.g. Paraffins, tetrahydronaphthalene, alkylated naphthalenes and their derivatives, alkylated benzenes and their derivatives, alcohols such as methanol, ethanol, propanol, butanol and cyclohexanol, gycols, ketones such as cyclohexanone, gamma-butyrolactone, dimethyl fatty acid amides, fatty acids and fatty acid esters and highly polar solvents, eg Amines such as N-methylpyrrolidone, into consideration.
  • organic solvents such as medium to high boiling point mineral oil fractions such as kerosene and diesel oil, coal tar oils and oils of vegetable or animal origin, aliphatic
  • Solid carriers are mineral earths such as silicic acids, silica gels, silicates, talc, kaolin, limestone, lime, chalk, bolus, loess, clay, dolomite, diatomaceous earth, calcium and magnesium sulfate, magnesium oxide, ground plastics, fertilizers such as ammonium sulfate, ammonium phosphate, Ammonium nitrate, ureas and vegetable products such as cereal flour, tree bark, wood and nutshell flour, cellulose powder or other solid carriers.
  • mineral earths such as silicic acids, silica gels, silicates, talc, kaolin, limestone, lime, chalk, bolus, loess, clay, dolomite, diatomaceous earth, calcium and magnesium sulfate, magnesium oxide, ground plastics, fertilizers such as ammonium sulfate, ammonium phosphate, Ammonium nitrate, ureas and vegetable products such as cereal flour, tree bark, wood and nut
  • alkali alkaline earth
  • ammonium salts of aromatic sulfonic acids eg. B. of lignin (Borresperse ® grades, Borregaard, Norway), phenol, naphtha lin (Morwet ® types, Akzo Nobel, USA) and dibutyl (nekal ® - types, BASF, Germany), and of fatty acids , Alkyl and alkylaryl sulfonates, alkyl, lauryl ether and fatty alcohol sulfates, as well as salts of sulfated hexa-, hepta- and octadecanols and of fatty alcohol glycol ethers, condensation products of sulfonated naphthalene and its derivatives with formaldehyde, condensation products of naphthalene or of na
  • thickeners ie, compounds that give the composition a modified flow properties, ie high viscosity at rest and low viscosity in motion
  • thickeners are polysaccharides and organic and inorganic sheet minerals, such as xanthan gum (Kelzan ®, CP Kelco, U.S.A.), Rhodopol ® 23 (Rhodia, France) or Veegum ® (RT Vanderbilt, USA) or attaclay ® (Engelhard Corp., NJ, USA).
  • Bactericides may be added to stabilize the composition.
  • bactericides are those based on dichlorophen and benzyl alcohol hemiformal (Proxel ®.. Of Messrs. ICI or Acetide ® RS from Thor Chemie and Kathon ® MK from Rohm & Haas) and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones (Acetide ® MBS Fa. Thor Chemie).
  • Suitable antifreeze agents are ethylene glycol, propylene glycol, urea and glycerol.
  • defoamers are silicone emulsions (such as, for example, silicone ® SRE, Wacker, Germany or Rhodorsil ®, Rhodia, France), long chain alcohols, fatty acids, salts of fatty acids, organofluorine compounds and mixtures thereof.
  • colorants are pigments which are sparingly soluble both in water and in water
  • Water-soluble dyes examples which may be mentioned are those under the names Rhodamine B, CI Pigment Red 112 and CI Solvent Red 1, Pigment Blue 15: 4, Pigment Blue 15: 3, Pigment Blue 15: 2, Pigment Blue 15: 1, Pigment Blue 80, Pigment yel- low 1, Pigment yellow 13, Pigment red 48: 2, Pigment red 48: 1, Pigment red 57: 1, Pigment red 53: 1, Pigment orange 43, Pigment orange 34, Pigment orange 5, Pigment green 36 Pigment green 7, Pigment white 6, Pigment brown 25, Basic violet 10, Basic violet 49, Acid red 51, Acid red 52, Acid red 14, Acid blue 9, Acid yellow 23, Basic red 10, Basic red 108 well-known dyes and pigments.
  • adhesives are polyvinyl pyrrolidone, polyvinyl acetate, polyvinyl alcohol and
  • emulsions, pastes or oil dispersions come mineral oil fractions of medium to high boiling point, such as kerosene or diesel oil, coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, eg toluene, xylene, Paraffin, tetrahydronaphthalene, alkylated naphthalenes or their derivatives, methanol, ethanol, propanol, butanol, cyclohexanol, cyclohexanone, isophorone, strongly polar Solvent, for example dimethyl sulfoxide, N-methylpyrrolidone or water into consideration.
  • mineral oil fractions of medium to high boiling point such as kerosene or diesel oil, coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, eg toluene, xylene, Paraffin, tetrahydronaphthalene, alkyl
  • Powders, litter and dusts can be prepared by mixing or joint grinding of the compounds I and, if present, other active ingredients with at least one solid carrier.
  • Granules for. As coated, impregnated and homogeneous granules can be prepared by binding the active ingredients to at least one solid carrier.
  • Solid carriers are z.
  • mineral earths such as silica gels, silicates, talc, kaolin, Attaclay, limestone, lime, chalk, bolus, loess, clay, dolomite, diatomaceous earth, calcium and magnesium sulfate, magnesium oxide, ground plastics, fertilizers such as ammonium sulfate, ammonium phosphate, ammonium nitrate , Ureas and vegetable products such as cereal flour, bark, wood and nutshell flour, cellulose powders and other solid carriers.
  • composition types are: 1. Compositions for dilution in water i) Water-soluble concentrates (SL, LS)
  • Emulsions (EW, EO, ES)
  • the active compounds 25 parts by weight of the active compounds are dissolved in 35 parts by weight of xylene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (in each case 5 parts by weight).
  • This mixture is added by means of an emulsifying machine (eg Ultra-Turrax) in 30 parts by weight of water and brought to a homogeneous emulsion. Dilution in water results in an emulsion.
  • the composition has an active ingredient content of 25 wt .-%. v) suspensions (SC, OD, FS)
  • the active ingredients 20 parts by weight of the active ingredients are comminuted with the addition of 10 parts by weight of dispersants and wetting agents and 70 parts by weight of water or an organic solvent in a stirred ball mill to a fine active substance suspension. Dilution in water results in a stable suspension of the active ingredient.
  • the active ingredient content in the composition is 20% by weight.
  • Water-dispersible and water-soluble granules (WG, SG) 50 parts by weight of the active ingredients are finely ground with the addition of 50 parts by weight of dispersants and wetting agents and prepared by means of technical equipment (eg extrusion, spray tower, fluidized bed) as water-dispersible or water-soluble granules. Dilution in water results in a stable dispersion or solution of the active ingredient.
  • the composition has an active substance content of 50% by weight.
  • Water-dispersible and water-soluble powders WP, SP, SS, WS
  • compositions of the compounds according to the invention generally contain from 0.01 to 95% by weight, preferably from 0.1 to 90% by weight, of the compounds I.
  • the compounds are preferably present in a purity of from 90% to 100%, preferably 95% used up to 100%.
  • compositions for the treatment of plant propagation materials, in particular seed, usually water-soluble concentrates (LS), suspensions (FS), dusts (DS), water-dispersible and water-soluble powders (WS, SS), emulsions (ES), emulsifiable concentrates (EC) and gels ( GF).
  • LS water-soluble concentrates
  • FS suspensions
  • DS dusts
  • WS water-dispersible and water-soluble powders
  • ES emulsions
  • EC emulsifiable concentrates
  • gels GF
  • These compositions can be applied to the propagating materials, in particular seeds, undiluted or, preferably, diluted.
  • the corresponding composition can be diluted 2 to 10 times, so that 0.01 to 60% by weight, preferably 0.1 to 40% by weight, of active compounds are used in the compositions to be used for the pickling. fabric are present.
  • the application can be done before or during sowing.
  • the treatment of plant propagation material in particular the treatment of seed, are known to the person skilled in the art and are carried out by dusting, coating, pelleting, dipping or impregnating the plant propagation material, wherein the treatment preferably takes place by pelleting, coating and dusting or by furrow treatment, so that z. B. premature germination of the seed is prevented.
  • suspensions are preferably used.
  • such compositions contain 1 to 800 g / l active ingredient, 1 to 200 g / l surfactants, 0 to 200 g / l antifreeze, 0 to 400 g / l binder, 0 to 200 g / l dyes and solvents, preferably water ,
  • the compounds may be used as such or in the form of their compositions, e.g. B. in the form of directly sprayable solutions, powders, suspensions, dispersions, emulsions, oil dispersions, pastes, dusts, scattering agents or granules by spraying, atomizing, dusting, scattering, coating, dipping or pouring.
  • composition types depend entirely on the intended use; In any case, they should ensure the finest possible distribution of the active compounds according to the invention.
  • Aqueous application forms can be prepared from emulsion concentrates, pastes or wettable powders (wettable powders, oil dispersions) by adding water.
  • the substances as such or dissolved in an oil or solvent, can be homogenized in water by means of wetter, tackifier, dispersant or emulsifier.
  • the active compound concentrations in the ready-to-use preparations can be varied within wide ranges. In general, they are between 0.0001 and 10%, preferably between 0.01 and 1%.
  • the active ingredients can also be successfully used in the ultra-low-volume (ULV) process, whereby it is possible to apply compositions containing more than 95% by weight of active ingredient or even the active ingredient without additives.
  • UUV ultra-low-volume
  • the application rates in the application in crop protection depending on the nature of the desired effect between 0.001 and 2.0 kg of active ingredient per ha, preferably between 0.005 and 2 kg per ha, more preferably between 0.05 and 0.9 kg per ha, in particular between 0.1 and 0.75 kg per ha.
  • the application rate of active ingredient depends on the type of application and the desired effect. Usual application rates are, for example, 0.001 g to 2 kg in material protection, preferably 0.005 g to 1 kg of active ingredient per cubic meter of material treated.
  • Oils of various types, wetting agents, adjuvants, herbicides, bactericides, other fungicides and / or pesticides may also be added to the active substances or the compositions containing them, if appropriate also immediately before use (tank mix). These agents can be added to the compositions according to the invention in a weight ratio of 1: 100 to 100: 1, preferably 1:10 to 10: 1.
  • adjuvants in this sense are in particular: organically modified polysiloxanes, eg. B. Break Thru S 240® ; Alcohol alkoxylates, eg. B. Atplus 245 ®, Atplus MBA ® 1303 Plurafac ® LF 300 ® and Lutensol ON 30; EO-PO block polymers, eg. B. Pluronic RPE 2035 ® and Genapol B ®; Alcohol ethoxylates, eg. B. Lutensol ® XP 80; and sodium dioctylsulfosuccinate, e.g. B. Leophen ® RA.
  • organically modified polysiloxanes eg. B. Break Thru S 240®
  • Alcohol alkoxylates eg. B. Atplus 245 ®, Atplus MBA ® 1303
  • Plurafac ® LF 300 ® and Lutensol ON 30 EO-PO block polymers, eg.
  • compositions of the invention may also be present in the application form as fungicides together with other active ingredients, for.
  • fungicides As with herbicides, insecticides, growth regulators, fungicides or with fertilizers, as a pre-mix or possibly only immediately before use (tank mix).
  • the activity spectrum can be broadened or resistance developments can be prevented. In many cases, synergistic effects are obtained.
  • Azoxystrobin Dimoxystrobin, Enestroburin, Fluoxastrobin, Kresoxim-methyl, Metomino Strobin, Orysastrobin, Picoxystrobin, Pyraclostrobin, Pyribencarb, Trifloxystrobin, 2- (2- (6- (3-Chloro-2-methyl-phenoxy) -5-fluoro) pyrimidin-4-yloxy) -phenyl) -2-methoxy-imino-N-methyl-acetamide, 2- (ortho - ((2,5-dimethylphenyl-oxymethylene) -phenyl) -3-methoxy-acrylic acid methyl ester, 3-methoxy- Methyl 2- (2- (N- (4-methoxy-phenyl) -cyclopropanecarboximidoylsulfanylmethyl) -phenyl) acrylate, 2- (2- (3- (2,6-dichlorophenyl) -1-methyl-allylidene
  • Benzoic acid amides flumetover, fluopicolide, fluopyram, zoxamide, N- (3-ethyl-3,5,5-trimethylcyclohexyl) -3-formylamino-2-hydroxybenzamide;
  • carboxamides carpropamide, diclocymet, mandipropamide, oxytetracycline, silthiofam, N- (6-methoxypyridin-3-yl) cyclopropanecarboxamide;
  • Triazoles azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole , Prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1- (4-chloro-phenyl) -2 - ([1, 2,4] triazol-1-yl) -cycloheptanol;
  • - imidazoles cyazofamide, imazalil, imazalil sulfate, pefurazoate, prochloraz, triflumizole; Benzimidazoles: benomyl, carbendazim, fuberidazole, thiabendazole;
  • Pyridines fluazinam, pyrifenox, 3- [5- (4-chloro-phenyl) -2,3-dimethyl-isoxazolidin-3-yl] -pyridine, 3- [5- (4-methyl-phenyl) -2, 3-dimethyl-isoxazolidin-3-yl] -pyridine, 2,3,5,6-tetrachloro-4-methanesulfonylpyridine, 3,4,5-trichloropyridine-2,6-dicarbonitrile, N- (1 - (5-Bromo-3-chloro-pyridin-2-yl) -ethyl) -2,4-dichloronotinamide, N - ((5-bromo-3-chloro-pyridin-2-yl) -methyl) -2,4 -dichlornicotinamid;
  • - piperidines fenpropidine
  • Dicarboximides fluorimide, iprodione, procymidone, vinclozolin;
  • non-aromatic 5-membered heterocycles famoxadone, fenamidone, flutianil, octhilinone, probenazole, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydropyrazole-1-thiocarboxylic acid allyl ester;
  • Thio and dithiocarbamates Ferbam, Mancozeb, Maneb, Metam, Methasulphocarb, Metiram, Propineb, Thiram, Zineb, Ziram; Carbamates: Diethofencarb, Benthiavalicarb, Iprovalicarb, Propamocarb, Propamocarb hydrochloride, Valiphenal, N- (1- (1- (4-cyanophenyl) ethanesulfonyl) -but-2-yl) carbamic acid- (4-fluorophenyl) ester;
  • antibiotics kasugamycin, kasugamycin hydrochloride hydrate, polyoxines, streptomycin, validamycin A;
  • Nitrophenyl derivatives binapacryl, diclorane, dinobutone, dinocap, nitrothal-isopropyl, tecnazene;
  • fentin salts such as fentin acetate, fentin chloride, fentin hydroxide
  • Sulfur-containing heterocyclyl compounds dithianone, isoprothiolanes
  • Organophosphorus compounds edifenphos, fosetyl, fosetyl-aluminum, Iprobenfos, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
  • Organochlorine compounds chlorothalonil, dichlofluanid, dichlorophene, flusulphamide, hexachlorobenzene, pencycuron, pentachlorophenol and its salts, phthalide, quintozene, thiophanate-methyl, tolylfluanid, N- (4-chloro-2-nitro-phenyl) -N-ethyl-4- methyl-benzenesulfonamide;
  • Inorganic active ingredients phosphorous acid and its salts, Bordeaux broth, copper salts such as copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;
  • Amino acid analogues bilanafos, glyphosate, glufosinate, sulfosate;
  • Aryloxyphenoxypropionates Clodinafop, Cyhalofop-butyl, Fenoxaprop, Fluazifop, Haloxyfop, Metamifop, Propaquizafop, Quizalofop, Quizalofop-P-tefuryl;
  • Bipyridyls diquat, paraquat;
  • Carbamates and thiocarbamates asulam, butylates, carbamides, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinates, orbencarb, phenmedipham, prosulphocarb, pyributicarb, thiobencarb, triallates; - cyclohexanediones: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim;
  • Diphenyl ether acifluorfen, aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, oxyfluorfen;
  • Hydroxybenzonitriles bromoxynil, dichlobenil, loxynil;
  • Imidazolinone imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr;
  • Phenoxyacetic acids clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, mecoprop;
  • - pyridines aminopyralid, clopyralid, diflufenican, dithiopyr, fluridone, fluroxypyr, pilinoram, picolinafen, thiazopyr;
  • Sulfonylureas amidosulfuron, azimsulfuron, bensulfuron, chlorimuron-ethyl, chlorosulfuron, cinosulfuron, cyclosulfamuron, ethoxysulfuron, flazasulfuron, flucosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, lodosulfuron, mesosulfuron, metsulfuron-methyl, nicosulfuron, oxasulfuron, primisulfuron, prosul furon, pyrazosulfuron, rimsulfuron, sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron, trifloxysulfuron, triflusulfuron, tritosulfuron, 1 - ((2-chloro-6-prop
  • Triazines ametryn, atrazine, cyanazine, dimethametryn, ethiozine, hexazinone, metachronon, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, triaziflam;
  • acetolactate synthase bispyribac sodium, cloransulam methyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, orthosulphamuron, penoxsulam, propoxycarbazone, pyribambenzpropyl, pyribenzoxime, Pyriftalid, Pyriminobac-methyl, Pyrimisulfan, Pyrithiobac, Pyroxasulfone, Pyroxsulam;
  • Organo (thio) phosphates acephate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulphoton, ethion, fenitrothion, fenthione, isoxathione, malathion, methamidophosphate, methidathion , Methyl parathion, mevinphos, monocrotophos, oxydemeton
  • Carbamates alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenoxycarb, furathiocarb, methiocarb, methomyl, oxamyl, pirimicarb,
  • - pyrethroids allethrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, imiprothrin, lambda-cyhalo- thrin, permethrin, prallethrin , Pyrethrin I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin,
  • Insect growth inhibitors a) chitin synthesis inhibitors: benzoylureas: chlorofluorazuron, cyramazine, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; Buprofezin, diofenolan, hexythiazox, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide,
  • GABA antagonists endosulfan, ethiprole, fipronil, vaniliprole, pyrafluprole, pyriprole, 5-amino-1 - (2,6-dichloro-4-methyl-phenyl) -4-sulfinamoyl-1H-pyrazole-3-thiocarbon acid amide;
  • Macrocyclic lactones Abamectin, Emamectin, Milbemectin, Lepimectin, Spinosid, Spinetoram;
  • METI II and III substances Acequinocyl, Fluacyprim, Hydramethylnon;
  • Inhibitors of oxidative phosphorylation cyhexatin, diafenthiuron, fenbutatin oxide, propargite; Inhibitors of the sloughing of insects: Cryomazine;
  • Inhibitors of mixed function oxidases piperonyl butoxide
  • the present invention also relates in particular to fungicidal compositions which comprise at least one compound of the general formula I and at least one further crop protection active ingredient, in particular at least one fungicidal active ingredient, eg. One or more, e.g. 1 or 2 active compounds of the abovementioned groups A) to F) and optionally one or more agriculturally suitable carriers.
  • fungicidal active ingredient eg. One or more, e.g. 1 or 2 active compounds of the abovementioned groups A) to F
  • agriculturally suitable carriers optionally one or more agriculturally suitable carriers.
  • Common application within the meaning of this application means that the at least one compound I and the at least one other active ingredient at the same time at the site of action (ie the attacking plant-damaging fungi and their habitat such as infested plants, plant propagation materials, insebesondere seed, soil, materials or rooms and the before Fungal attack on plants to be protected, plant propagation materials, in particular seeds, soil, materials or spaces) in an amount sufficient for effective control of fungal growth.
  • This can be achieved by combining the compounds I and at least one further active ingredient together in a common active ingredient preparation.
  • compositions of the invention comprising a compound I and another active agent, e.g. contain an active compound from groups A) to I
  • the weight ratio of compound I to the other active ingredient depends on the weight ratio of compound I to 1 further active ingredient on the properties of the respective active ingredients, it is usually in the range of 1: 100 bis 100: 1, often in the range from 1:50 to 50: 1, preferably in the range from 1:20 to 20: 1, particularly preferably in the range from 1:10 to 10: 1, in particular in the range from 1: 3 to 3 :1.
  • compositions according to the invention comprising an active substance I and a further active ingredient and a further active ingredient, eg. B. contain two different agents from groups A) to I)
  • the weight ratio of compound I to the first further active ingredient depends on the properties of the respective active ingredients, preferably in the range of 1: 50 to 50: 1 and in particular in the range from 1:10 to 10: 1.
  • the weight ratio of compound I to the second further active ingredient is preferably in the range from 1:50 to 50: 1, in particular in the range from 1:10 to 10: 1.
  • the weight ratio of 1. further active ingredient to the second further active ingredient is preferably in the range from 1:50 to 50: 1, in particular in the range from 1:10 to 10: 1.
  • composition according to the invention can be mixed individually or already mixed or packaged as parts according to the kit of parts and reused.
  • kits may contain one or more, even all, components that can be used to prepare an agrochemical composition of the invention.
  • these kits may contain one or more fungicidal component (s) and / or an adjuvant component and / or an insecticidal component and / or a growth regulator component and / or a herbicide.
  • fungicidal component s
  • an adjuvant component / or an insecticidal component and / or a growth regulator component and / or a herbicide.
  • One or more components may be combined or pre-formulated.
  • the components may be combined together and packaged in a single container such as a vessel, bottle, can, bag, sack or canister.
  • two or more components of a kit may be packaged separately, ie, not pre-formulated or mixed.
  • Kits may contain one or more separate containers such as Containers, bottles, cans, bags, sacks or canisters, each container containing a separate component of the agrochemical composition.
  • the components of the composition according to the invention can be mixed individually or already mixed or packaged as parts according to the modular principle ("kit of parts") and reused. In both forms, one component can be used separately or together with the other components or as part of a kit of parts according to the invention for the preparation of the mixture according to the invention.
  • the user usually uses the composition according to the invention for use in a pre-metering device, in the back splash, in the spray tank or in the spray plane.
  • the agrochemical composition with water and / or buffer is brought to the desired application concentration, optionally further adjuvants are added, and thus the ready-spray mixture or the agrochemical composition according to the invention is obtained.
  • 50 to 500 liters of ready-spray mixture per hectare of agricultural land preferably 100 to 400 liters.
  • the user may include individual components such as for example, parts of a kit or a mixture of two or three of the composition according to the invention itself mix in the spray tank and optionally add further auxiliaries (tank mix).
  • the user can mix both individual components of the composition according to the invention and partially premixed components, for example components containing compounds I and / or active compounds from groups A) to I), in the spray tank and optionally add further auxiliaries (tank mix). ,
  • the user can combine both individual components of the composition according to the invention and partially premixed components, for example components containing compounds I and / or active compounds from groups A) to I) (for example as a tank mix) or in succession apply.
  • compositions of a compound I with at least one active ingredient from group A) (component 2) of the strobilurins and especially selected from azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orysastrobin, picoxystrobin, pyraclostrobin and trifloxystrobin.
  • compositions of a compound I having at least one active compound selected from the group B) (component 2) of the carboxamides and especially selected from bixafen, boscalid, isopyrazam, fluopyram, penflufen, penthiopyrad, sedaxanes, fenhexamide, metalaxyl , Mefenoxam, ofurace, dimethomorph, flumorph, fluopicolide (picobenzamide), zoxamide, carpropamide, man- dipropamide and N- (3 ', 4', 5'-trifluorobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide.
  • compositions of a compound I having at least one active compound selected from group C) (component 2) of the azoles and especially selected from cyproconazole, difenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, myclobutanil, penconazole , Propiconazole, Prothioconazole, Triadimefon, Triadimenol, Tebuconazole, Tetraconazole, Triticonazole, Prochloraz, Cyazofamide, Benomyl, Carbendazim and Ethaboxam.
  • compositions of a compound I having at least one active compound selected from the group E) (component 2) of the carambamates and especially selected from mancozeb, metiram, propineb, thiram, iprovalacarb, benthiavalicarb and propamocarb.
  • compositions of a compound I with at least one active ingredient selected from the fungicides of group F) (component 2) and especially selected from dithianone, fentin salts such as fentin acetate, fosetyl, fosetyl-aluminum, H3PO3 and their salts , Chlorothalonil, dichlofluanid, thiophosphate-methyl, copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, cymoxanil, metrafenone, spiroxamine and N-methyl-2- ⁇ 1 - [(5-methyl-3-trifluoromethyl-1H-pyrazole -1-yl) -acetyl] -piperidin-4-yl ⁇ -N - [(1R) -1, 2,3,4-tetrahydronaphthalen-1-yl] -4-thiazolecarboxamide.
  • fentin salts such as fentin acetate,
  • the present invention further relates to compositions of
  • Compound I component 1 with a further active ingredient (component 2), the latter being selected from the lines B-1 to B-347 in the column "component 2" of table B.
  • a further embodiment of the invention relates to those listed in Table B.
  • Compositions B-1 to B-347 wherein in each case one row of Table B corresponds to an agrochemical composition comprising an individualized in the present specification compounds of formula I (component 1) and the further indicated in the respective row further active compound from the groups A. ) to I) (component 2).
  • component 1 corresponds to a compound I which is individualized in Tables 1a to 324a.
  • the active compounds in the described compositions are each preferably present in synergistically effective amounts.
  • component 2 The active ingredients mentioned above as component 2, their preparation and their action against harmful fungi are known (cf .: http://www.alanwood.net/pesticides/); they are commercially available.
  • the compounds named after IUPAC, their preparation and their fungicidal action are also known (see Can. J.
  • compositions for mixtures of active ingredients in a known manner in the form of compositions containing in addition to the active ingredients, a solvent or solid carrier, for. B. in the manner as for compositions of the compounds I indicated.
  • compositions containing the compounds I With regard to the usual ingredients of such compositions, reference is made to the comments on the compositions containing the compounds I.
  • compositions for mixtures of active substances are suitable as fungicides for controlling harmful fungi. They are distinguished by outstanding activity against a broad spectrum of phytopathogenic fungi including soil-borne pathogens, which in particular from the classes of Plasmodiophoromycetes, Peronosporomycetes (Syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (Syn. Fungi imperfecti ) come. Furthermore, reference is made to the comments on the effectiveness of the compounds I and the compositions containing the compounds I.
  • Another object of the present invention is the use of compounds I and their pharmaceutically acceptable salts for the treatment of diseases, in particular the use of the compounds I as an antimycotic.
  • a pharmaceutical composition comprising at least one compound of the formula I and / or a pharmaceutically acceptable salt thereof.
  • Another embodiment relates to the use of a compound I and / or a pharmaceutically active salt thereof for the manufacture of an antimycotic.
  • Yet another object of the present invention is the use of compounds I and their pharmaceutically acceptable salts for the treatment of tumors in mammals, such as humans.
  • one embodiment of the invention relates to the use of a compound I and / or a pharmaceutically acceptable salt thereof for the manufacture of an agent which inhibits the growth of tumors and cancer in mammals.
  • cancer is meant in particular a malignant or malignant tumor, e.g. Breast cancer, prostate cancer, lung cancer, CNS cancer, melanocarcinoma, ovarian cancer or kidney cancer, especially in humans.
  • Yet another object of the present invention is the use of compounds I and their pharmaceutically acceptable salts for the treatment of viral infections, in particular viral infections, which lead to diseases in warm-blooded animals.
  • one embodiment of the invention relates to the use of a compound I and / or a pharmaceutically active salt thereof for the preparation a means of treating viral infections.
  • the viral diseases to be treated include retrovirus diseases such as: HIV and HTLV, influenza virus, rhinovirus diseases, herpes and the like.
  • the organic phase was separated, dried with Na 2 SO 4 and freed from the solvent.
  • the target compound was obtained in the form of a colorless solid (104 mg, 8%).
  • the mixture was at 100 ° C. for 40 min stirred under microwave irradiation, then stirred into ice-cold brine and extracted three times with MTBE. The combined organic phases were dried over Na 2 SO 4 and freed from the solvent.
  • the crude product was purified by column chromatography (silica gel, ethyl acetate / cyclohexane). After connection of the corresponding fractions, 154 mg, 15%) of the target compound were obtained.
  • the crude product was purified by column chromatography (silica gel, eluent: hexanes: dichloromethane, 4: 1) to obtain the corresponding bromoketone.
  • a solution of the bromoketone in acetone (30 mmol) was added dropwise with stirring to a mixture of 1, 2,4-triazole (48 mmol) and potassium carbonate (39 mmol) in acetone (50 ml). After stirring at room temperature for 18 hours, the mixture was filtered and the filtrate was concentrated in vacuo. The residue was taken up with ethyl acetate (50 ml) and washed with saturated NaCl solution (2x50 ml).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne des composés de formule (I), dans laquelle les variables ont les significations définies dans les revendications et la description.
PCT/EP2009/061615 2008-09-10 2009-09-08 Composés d'imidazole et de triazole, leur utilisation et produits contenant ces composés Ceased WO2010029065A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08164037.7 2008-09-10
EP08164037 2008-09-10

Publications (1)

Publication Number Publication Date
WO2010029065A1 true WO2010029065A1 (fr) 2010-03-18

Family

ID=41476843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/061615 Ceased WO2010029065A1 (fr) 2008-09-10 2009-09-08 Composés d'imidazole et de triazole, leur utilisation et produits contenant ces composés

Country Status (3)

Country Link
AR (1) AR073285A1 (fr)
UY (1) UY32107A (fr)
WO (1) WO2010029065A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011086988A1 (fr) * 2010-01-12 2011-07-21 国立大学法人 東京大学 Inhibiteur de biosynthèse de strigolactone
CN105820129A (zh) * 2016-03-24 2016-08-03 华中师范大学 一种三唑炔类化合物及其应用

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069290A1 (fr) * 1981-07-02 1983-01-12 BASF Aktiengesellschaft Dérivés azolyles, leur procédé de préparation et les fongicides les contenant
EP0079006A1 (fr) * 1981-11-10 1983-05-18 Bayer Ag Azolyl-alkénones et -ols, leur procédé de préparation et leur application comme agents régulateurs de croissance des plantes et fongicides
EP0109476A1 (fr) * 1982-03-16 1984-05-30 Bayer Ag Phénoxypropyltriazolyl-cétones et -carbinols, leur procédé de préparation et leur application comme fongicides ainsi que des intermédiaires de synthèse
EP0159586A2 (fr) * 1984-04-26 1985-10-30 BASF Aktiengesellschaft Dérivés d'azoles, leur procédé de préparation et fongicides les contenant
EP0178587A2 (fr) * 1984-10-17 1986-04-23 BASF Aktiengesellschaft Benzyloxyalkylazoles et fongicides les contenant
EP0199982A2 (fr) * 1985-04-01 1986-11-05 BASF Aktiengesellschaft Dérivés azoliques, leur procédé de préparation et composition pour régler la croissance des plantes
EP0200149A2 (fr) * 1985-04-27 1986-11-05 BASF Aktiengesellschaft 1,3-Dioxane-5-yl alkyl triazoles, leur préparation, leur utilisation comme régulateur pour la croissance des plantes et composition
EP0236884A1 (fr) * 1986-03-04 1987-09-16 BASF Aktiengesellschaft Procédé pour la préparation de composés phénoxyalcanoltriazoliques et produits intermédiaires à cet effet
EP0297393A2 (fr) * 1987-07-01 1989-01-04 Bayer Ag Dérivés de 1-phénoxy-3-triazolyl-hex-1-ènes

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069290A1 (fr) * 1981-07-02 1983-01-12 BASF Aktiengesellschaft Dérivés azolyles, leur procédé de préparation et les fongicides les contenant
EP0079006A1 (fr) * 1981-11-10 1983-05-18 Bayer Ag Azolyl-alkénones et -ols, leur procédé de préparation et leur application comme agents régulateurs de croissance des plantes et fongicides
EP0109476A1 (fr) * 1982-03-16 1984-05-30 Bayer Ag Phénoxypropyltriazolyl-cétones et -carbinols, leur procédé de préparation et leur application comme fongicides ainsi que des intermédiaires de synthèse
EP0159586A2 (fr) * 1984-04-26 1985-10-30 BASF Aktiengesellschaft Dérivés d'azoles, leur procédé de préparation et fongicides les contenant
EP0178587A2 (fr) * 1984-10-17 1986-04-23 BASF Aktiengesellschaft Benzyloxyalkylazoles et fongicides les contenant
EP0199982A2 (fr) * 1985-04-01 1986-11-05 BASF Aktiengesellschaft Dérivés azoliques, leur procédé de préparation et composition pour régler la croissance des plantes
EP0200149A2 (fr) * 1985-04-27 1986-11-05 BASF Aktiengesellschaft 1,3-Dioxane-5-yl alkyl triazoles, leur préparation, leur utilisation comme régulateur pour la croissance des plantes et composition
EP0236884A1 (fr) * 1986-03-04 1987-09-16 BASF Aktiengesellschaft Procédé pour la préparation de composés phénoxyalcanoltriazoliques et produits intermédiaires à cet effet
EP0297393A2 (fr) * 1987-07-01 1989-01-04 Bayer Ag Dérivés de 1-phénoxy-3-triazolyl-hex-1-ènes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011086988A1 (fr) * 2010-01-12 2011-07-21 国立大学法人 東京大学 Inhibiteur de biosynthèse de strigolactone
CN105820129A (zh) * 2016-03-24 2016-08-03 华中师范大学 一种三唑炔类化合物及其应用

Also Published As

Publication number Publication date
AR073285A1 (es) 2010-10-28
UY32107A (es) 2010-03-26

Similar Documents

Publication Publication Date Title
WO2010029066A1 (fr) Composés d'imidazole et de triazole, leur utilisation et produits contenant ces composés
EP2234488A2 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
EP2224812A2 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
EP2442654A2 (fr) Mélanges fongicides
WO2010146113A1 (fr) Derives triazolyle antifongiques 1, 2, 4 ayant un substituant 5-soufre
EP2235005A2 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
EP2334648A1 (fr) Composés d'imidazole et de triazole, leur utilisation et agents les contenant
EP2334650A1 (fr) Composés d'imidazole et de triazole, leur utilisation et agents les contenant
EP2346838A1 (fr) Composés triazole et imidazole, leur utilisation et agents les contenant
EP2334649A1 (fr) Composés d'imidazole et de triazole, leur utilisation et agents les contenant
EP2334654A1 (fr) Composés de triazole, leur utilisation ainsi qu'agents les contenant
EP2334656A1 (fr) Composés triazoles, leur utilisation et agents les contenant
EP2328878A1 (fr) Composés de triazole, leur utilisation ainsi qu'agents les contenant
WO2010029003A1 (fr) Composés triazoles, leur utilisation et agents les contenant
JP2012530109A (ja) 抗菌性１，２，４−トリアゾリル誘導体
EP2346839A1 (fr) Composés triazole et imidazole, leur utilisation et agents les contenant
WO2010031842A1 (fr) Composés d'imidazole et de triazole, leur utilisation et agents les contenant
WO2010029065A1 (fr) Composés d'imidazole et de triazole, leur utilisation et produits contenant ces composés
EP2346835A1 (fr) Composés d'imidazole et de triazole, leur utilisation et agents les contenant
EP2334663A1 (fr) Composés d'imidazole et de triazole, leur utilisation et produits contenant ces composés
EP2331509A1 (fr) Composés d'imidazole et de triazole, leur utilisation ainsi qu'agents les contenant
WO2010149758A1 (fr) Dérivés de 1,2,4-triazole antifongiques
EP2334655A1 (fr) Composés d'imidazole et de triazole utilisés comme fongicides
WO2010029029A1 (fr) Composés d'imidazole et de triazole, leur utilisation ainsi qu'agents les contenant
WO2010029028A1 (fr) Composés d'imidazole, leur utilisation ainsi qu'agents les contenant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09782750

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09782750

Country of ref document: EP

Kind code of ref document: A1